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“The woods are lovely dark and deep,
But I have promises to keep,
And miles to go before I sleep,
And miles to go before I sleep”

-

Robert Frost
(1874-1963)

From Stopping by Woods on a Snowy Evening
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ABSTRACT

DEVELOPMENT AND APPLICATIONS OF THE HINT FORCEFIELD IN PREDICTION
OF ANTIBIOTIC EFFLUX AND VIRTUAL SCREENING FOR ANTIVIRALS

A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
by
AURIJIT SARKAR
M.Sc. Shri GS Institute of Technology & Science, Indore MP, India 2003
B.Sc. Devi Ahilya University, Indore MP, India 2000

VIRGINIA COMMONWEALTH UNIVERSITY, 2010

Advisor: GLEN EUGENE KELLOGG, Ph.D.
ASSOCIATE PROFESSOR, DEPARTMENT OF MEDICINAL CHEMISTRY &
INSTITUTE FOR STRUCTURAL BIOLOGY AND DRUG DISCOVERY

This work was aimed at developing novel tools that utilize HINT, an empirical
forcefield capable of quantitating both hydrophobic and hydrophilic (hydropathic)
interactions, for implementation in theoretical biology and drug discovery/design.

xiii

The role of hydrophobicity in determination of macromolecular structure and
formation of complexes in biological molecules is undeniable and has been the subject
of research across several decades. Hydrophobicity is introduced, with a review of its
history and contemporary theories. This is followed by a description of various methods
that quantify this all-pervading phenomenon and their use in protein folding and
contemporary drug design projects – including a detailed overview of the HINT
forcefield.
The specific aim of this dissertation is to introduce our attempts at developing
new methods for use in the study of antibacterial drug resistance and antiviral drug
discovery. Multidrug efflux is commonly regarded as a fast growing problem in the field
of medicine. Several species of microbes are known to have developed resistance
against almost all classes of antibiotics by various modes-of-action, which include
multidrug transporters (a.k.a. efflux pumps). These proteins are present in both grampositive and gram-negative bacteria and extrude molecules of various classes. They
protect the efflux pump-expressing bacterium from harmful effects of exogenous agents
by simply evacuating the latter. Perhaps the best characterized mechanism amongst
these is that of the AcrA-AcrB-TolC efflux pump. Data is available in literature and
perhaps also in proprietary databases available with pharmaceutical companies,
characterizing this pump in terms of the minimum inhibitory concentration ratios (MIC
ratios) for various antibiotics. We procured a curated dataset of 32 β-lactam and 12
antibiotics of other classes from this literature. Initial attempts at studying the MIC ratios
of β-lactam antibiotics as a function of their three dimensional topology via 3D-

xiv

quantitative structure activity relationship (3D-QSAR) technology yielded seemingly
good models. However, this methodology is essentially designed to address single
receptor-ligand interactions. Molecules being transported by the efflux pump must
undoubtedly be involved in multiple interactions with the same. Notably, such methods
require a pharmacophoric overlap of ligands prior to the generation of models, thereby
limiting their applicability to a set of structurally-related compounds. Thus, we designed
a novel method that takes various interactions between antibiotic agents and the AcrAAcrB-TolC pump into account in conjunction with certain properties of the drugs. This
method yielded mathematical models that are capable of predicting high/low efflux with
significant efficiency (>93% correct). The development of this method, along with the
results from its validation, is presented herein.
A parallel aim being pursued by us is to discover inhibitors for hemagglutininneuraminidase (HN) of human parainfluenza virus type 3 (HPIV3) by in silico screening.
The basis for targeting HN is explored, along with commentary on the methodology
adopted during this effort. This project yielded a moderate success rate of 34%,
perhaps due to problems in the computational methodology utilized. We highlight one
particular problem – that of emulating target flexibility – and explore new avenues for
overcoming this obstacle in the long run. As a starting point towards enhancing the tools
available to us for virtual screening in general (and for discovering antiviral compounds
in specific), we explored the compatibility between sidechain rotamer libraries and the
HINT scoring function. A new algorithm was designed to optimize amino acid residue
sidechains, if provided with the backbone coordinates, by generating sidechain

xv

positions using the Dunbrack and Cohen backbone-dependent rotamer library and
scoring them with the HINT scoring function. This rotamer library was previously used
by its developers previously to design a very successful sidechain optimization
algorithm called SCWRL. Output structures from our algorithm were compared with
those from SCWRL and showed extraordinary similarities as well as significant
differences, which are discussed herein. This successful implementation of HINT in our
sidechain optimization algorithm establishes the compatibility between this forcefield
and sidechain rotamer libraries. Future aims in this project include enhancement of our
current algorithm and the design of a new algorithm to explore partial induced-fit in
targets aimed at improving current docking methodology.
This work shows significant progress towards the implementation of our
hydropathic force field in theoretical modeling of biological systems in order to enhance
our ability to understand atomistic details of inter- and intramolecular interactions which
must form the basis for a wide variety of biological phenomena. Such efforts are key to
not only to understanding the said phenomena, but also towards a solid basis for
efficient drug design in the future.

CHAPTER 1
HYDROPHOBICITY: THEORIES, ESTIMATION AND APPLICATIONS

1.1 HYDROPHOBICITY AND BIOLOGICAL PHENOMENA
Hydrophobicity (or lipophilicity) is a well-known and extensively studied
phenomenon. It is commonly understood to be the tendency of non-polar molecules to
form aggregates in order to reduce their surface of contact with polar molecules such as
water [1]. Its manifestations include simple observable macroscopic phenomena such
as the immiscibility of oil and water or modern techniques such as chromatographic
separation. The importance of hydrophobic interactions at the atomic or molecular scale
has long been recognized in various areas of science [1]. While the concepts have
changed and the applications have expanded, the fact remains that hydrophobic
interactions are often the driving force in a variety of physical and biological
phenomena, although they are often complemented by hydrophilic interactions.
Our hypothesis is that a large majority of biological phenomena can be explained
by explicitly addressing the hydrophobic and hydrophilic interactions between
molecules. In fact, we suggest that predictive models can be developed in order to
explain such phenomena by explicitly quantitating the extent of these interactions. This
work is a compilation of results aimed at demonstrating the validity of this hypothesis.

1

To begin, the concept of hydrophobic interactions is presented here, along with a
very short history and discussion of theoretical and experimental studies on the
phenomenon.

The same set of forces and interactions that partitions a molecule

between polar and hydrophobic solvent phases, i.e. determines its hydrophobicity, is
pervasive in all biological interactions including small molecule binding and protein
folding. An in-depth perspective on computational studies involving hydrophobic
interactions is presented. These studies include methods for estimation of the
hydrophobic nature of small and large biological molecules and applications of this in
drug discovery or design.
These are followed by an example of quantitative modeling in order to effectively
address some complex biological phenomena, specifically antibiotic transport by efflux
pumps, followed by an implementation of these interactions in drug discovery for
antiviral agents. Finally, a weakness of current methodology used in the aforementioned
discovery process is discussed, followed by laying grounds for development of new
hydropathy-based tools to address the same.
1.2 A BRIEF HISTORICAL OVERVIEW OF HYDROPHOBICITY
Even before the turn of the 20th century, the importance of hydrophobic
interactions in biological phenomena, particularly drug activity, was recognized by the
work of Meyer and Overton [2,3,4].

In 1937, Butler showed a linear relationship

between heat of hydration and entropy of hydration [5]. He estimated the energies of
interaction of different functional groups with water and showed that the heats of
2

hydration are additive in nature. He also explained that the heats of hydration do not
determine the free energy of interactions, but that there is a direct proportionality
between them. The reasons were unclear at this point, but it was hypothesized that
entropy might be dependent on the size of the ―cavity‖ that contains the molecule. The
importance of H-bonds was also briefly discussed as formation of H-bonds between
polar parts of the molecule causes an increase in entropy, which favors dissolution of an
otherwise non-polar molecule.
Frank and Evans, in the middle of the 20th century, described the formation of
―icebergs‖ of water around non-polar parts of molecules [6]. Their findings were based
on the deviation of entropy of vaporization for certain substances when dissolved in
aqueous and non-aqueous solutions.

The formation of a regularized lattice-like

structure of water molecules surrounding non-polar moieties has been experimentally
validated with crystallography [7] and is now more or less taken for granted. This theory
was extended to proteins by Klotz, who explained the variation in pKa, molecular
volume, denaturation and the masking of expected behavior of protein functional groups
in terms of this ―iceberg‖ formation [8]. In fact, the association of two molecules can
become energetically favorable due to the increase in entropy when these ordered
water molecules are scattered or disordered (see Figure 1.1).
Kauzmann first coined the term ―hydrophobic bond‖ in 1959, which caught the
attention of many scientists at the time; this notion was supported by a number of
research investigations of that era [9]. The work of Némethy, Scheraga and Steinberg
also supported the use of this term [10]. Perhaps it was the tendency of the non-polar
3

Figure 1.1 The Hydrophobic Effect. Hydrophobic molecules are surrounded by an
ordered cage of water molecules. When two such molecules come together, they
aggregate in order to reduce their surface area in contact with the polar water
molecules. This causes a number of water molecules to be removed from their ordered
formation, thus increasing disorder (increased entropy) and potentially making the
process energetically favorable.
4

substances to form aggregates that caused scientists to draw parallelisms with the
general definition of a bond – ―the tendency of two atoms to stay together in space‖.
Hydrophobic bonds have been described as endothermic, i.e., as temperature
increases their strength increases until a maximum value is reached at approximately
60˚C [10]. However, the stability of proteins depends on not only these hydrophobic
―bonds,‖ but also hydrogen bonds. These have an inverse behavior, i.e., they become
weaker with increasing temperature. Thus, as temperature increases beyond 60˚C,
both H-bonds and hydrophobic interactions decrease in strength, causing proteins to
unfold.
In the 1970s, Robert Hermann published a series of three papers on ―the theory
of hydrophobic bonding‖ [11-13] where the large negative entropy of partitioning a
hydrophobic molecule into a non-polar solvent was explained by the loss of order in
water molecules in direct contact with the hydrophobic surface.

The ordered

arrangement of water molecules on the surface of a molecule is due to dipole-dipole
interactions with the immediate next layer of waters. In effect, this phenomenon is
similar to surface-tension where the first layer arranges itself in order to reduce contact
with the hydrophobic air, while less order exists in the second and succeeding layers.
Order continues to decrease in layers away from the hydrophobic surface and there is a
linear, but inverse, correlation between hydrophobic surface area and its solubility in
water [11].

Hermann also determined that the free energy for hydration of a

hydrophobic molecule is linearly related to the number of water molecules that can be
packed around it. This first study did not take into account cavity curvature and was
5

restricted to small molecules. Later work [12] described a correlation between a
molecule‘s hydrophobic surface area and its solubility in water. Hermann also
addressed hydrophobic interactions at a distance [13] taking into account not only
solubility, but also the distances between hydrophobic entities with the Lennard-Jones
potential as has also been suggested by Reynolds et al [14]. Leo, Hansch and Jow
established a relationship between hydrophobicity and two other factors – the nature of
the solute surface and the molecular (CPK) volume [15]. The major innovation of this
study is that they used the partition coefficient for 1-octanol/water (LogPo/w) as a
measure of hydrophobicity rather than solubility. This parameter has been used almost
ubiquitously in studies thereafter. Most importantly, these observations could not be
explained by the simple concept of a ―hydrophobic bond‖, but rather as a complex
phenomenon involving the interplay of flexible molecules and solvent under particular
conditions.
The argument on semantics over the use of the term ―hydrophobic bond‖ has
continued ever since, but the fact that hydrophobic phenomena can explain a multitude
of observations in science cannot be ignored.

Here, we attempt to describe how

naming and characterizing this effect has changed the realms of computational
chemistry and drug design. A comprehensive review of the research on hydrophobicity
is available elsewhere [1] for those interested in the intricacies of experimental
approaches towards the phenomenon.

6

1.3 CALCULATIONS OF HYDROPHOBICITY AND THE HYDROPHOBIC EFFECT
1.3.1 Estimation of LogPo/w
Hansch and Leo published their seminal paper on the determination and uses of
partition coefficients in 1971 [16]. This paper was and perhaps continues to be, the most
comprehensive article on the subject. It explains the fundamentals of partition
phenomena and provides detailed descriptions of the history and theory of the same. It
also contains a very comprehensive tabulation of LogP values for various substances.
However, most interesting to theoreticians is the discussion of additive-constitutive
properties wherein the utilization of the Hammett equation in calculations of partitioning
free energy and the effects of various stereoelectronic effects on the partition coefficient
are described. Also, various uses of partition coefficients for such diverse research
topics as countercurrent distribution, measurement of equilibria, hydrophile-lipophile
balance, drug dissolution and ―hydrophobic bonding ability‖ are outlined. Of note, the
partitioning of alcohols between water and red blood cells was compared to their
partitioning between water and 1-octanol. The energy of partitioning per methylene
group was the same for both cases, i.e., approximately -690 cal mol-1.

The

repercussions of this quantification of hydrophobic interaction energies have been key
to drug design projects as well as computational chemistry.

The Hansch and Leo

method for theoretical estimation of molecular LogP values, which is the basis of the CLOGP method (vide infra), is also described in great detail.
A loose categorization of different methodologies for estimation of LogP is
provided in Table 1, complete with a few typical examples of each. Here, the discussion
7

of these methods will be limited to a general overview highlighting the application of
these methods in drug design and the relevance of accuracy for these prediction
methods in that context.

Several comprehensive reviews of the computational

estimation of octanol-water partition coefficients are available [17-21].
To commence, it is a monumental understatement to say that a lot of good
research has been done in this field. Many diverse empirical methods exist today that
predict LogP of various molecules with different degrees of context-dependent certainty
[17, 20]. Some of the major types are discussed below.
Table 1.1 Various types of methods for LogP calculations. This table shows a rough
classification of methods used for theoretical prediction of LogP for compounds.
Examples of all the different types are included.
Approach

Methodology

Example(s)

Substructure
approaches

Fragment-based
methods

Rekker’s method [22], Leo’s C-LOGP method
[23-27], ACD/LogP method [28]

Atom-based methods

XLOGP method
method [29-32]

Whole molecule
approaches

[33-35],

Molecular Lipophilicity MLP [107-108]
Potential and related
approaches
Topology descriptions

MS-WHIP [40]

Molecular Property
descriptions

Toulmin’s LogP method [41]

8

Ghose-Crippen

Fragment-based methods – Rekker‘s fragment based system was the first
fragment-based computational method to estimate LogP [22].

Fragment-based

methods implement and statistically deconvolve empirical data from experimental LogP
values of compounds. Scheme 1.1 contains a short example of this approach. In order
to explain the effect of inter-fragmental interactions, certain additive correction factors
are introduced. Several other algorithms of this type exist including the C-LOGP [23-27]
and ACD/LogP [28] methods. The criticism most often applied to this methodology is
that the fragmentation of the target molecule is ―arbitrary‖. This is not actually true for
C-LOGP as there is a complete and unambiguous set of rules. However, they can be
difficult to visualize and fragments can be much more complex than organic functional
groups. Thus, fragments observed in new molecules can be missing from the C-LOGP
database library, yielding poor predictions of LogP [17,20]. However, there are also
advantages to these methods: significant and complex electronic interactions are
automatically taken into account when they exist within a library fragment [20]; when the
fragments coincide with real organic functional groups their interpretation is intuitive; the
correction factors can be used to understand the relationship between functional groups
or the effect of the observed feature on solubility, e.g., factors representing aliphatic
chain branching explain the increased water solubility of branched hydrocarbons; and
since fragment methods are based on empirical data, their associated algorithms are
very fast and practical to implement in software.
Atom-based methods – These are similar to the fragment-based methods, but
assume the hydrophobicity of a molecule to be the sum of the individual atomic
9

contributions. Scheme 1.2 provides an overview of the principle behind atom-based
additive methodologies. Again, several methodologies of this type exist, including the
well known Ghose-Crippen [29-32] and XLOGP [33-35] methods.

Mostly these

algorithms avoid correction factors by taking into account these sorts of contributions
with a large set of atom types according to the individual environment it exists in within
the molecule [20]. In order to somewhat reduce the atom type set the XLOGP algorithm
implements a small number of correction factors.

The reduced dependence on

corrections is the major advantage of these methods. As described by Buchwald and
Bodor, the major disadvantage of this method is that often the molecule is ―more than a
sum of its parts‖ [17]. Furthermore, human interpretability is reduced as the size of the
atom database set grows and the correspondence with organic and medicinal chemistry
principles is lost.
Molecular methods – Over the last two decades quantum mechanical
calculations have been increasingly used in applied research including drug discovery,
particularly with respect to estimations of interactions between solute and solvent
molecules. A number of studies have used quantum chemical principles for estimation
of molecular hydrophobicity [17]. Early work includes that of Rogers and Cammarata
[36,37] and also that of Hopfinger and Battershell [38]. Klopman and Iroff used charge
densities to calculate partition coefficients [39].

More recently, Bravi and Wikel

described a method to predict LogP using a technology called Molecular Surface –
Weighted Holistic Invariant Parameters (MS-WHIP) [40].

Unfortunately, a relatively

large standard deviation between predicted and actual LogP was observed [18].
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Toulmin et al. described another prediction method for octanol/water partition
coefficients [41] that correlated minimized molecular electrostatic potentials with the Hbonding capability of molecules. In this method ΔLogP is defined as the difference
between LogPoct (logarithm of the 1-octanol/water partition coefficient) and their
predicted LogPhxd (logarithm of the hexadecane/water partition coefficient). H-bonding
capability has a profound effect on partition coefficients with a strong correlation
between ΔLogP and Vmin (minimized molecular electrostatic potential).

A strong

correlation was also reported between ΔLogP or LogPhxd and CNS penetration of
compounds, i.e., through the blood-brain barrier. This highlights the importance of Hbond donors and acceptors in normal partitioning phenomena.
Livingstone et al. described a method that uses neural networks (NN) to predict
LogP values from a training set of electrotopological descriptors [42] of 900 drug and
pesticide-like compounds [43].

Other studies involving artificial-intelligence utilize

parameters calculated by various methods in unsupervised-learning processes to
develop predictive models [44,45]. Taskinen and Yliruuski provide an in-depth analysis
of such models in their review on NN modeling [46]. They note that, while NN methods
are accurate in predicting LogP values of molecules within the size, functional group,
etc. confines of the training set, they are less accurate in predictions for molecules
outside the training set. However, this is the case for all LogP estimation methods.
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Scheme 1.1 Fragmental methods for determination of LogP values. Rekker‘s
method is highlighted with an example adapted from Mannhold and van de
Waterbeemd [18].
Fragmentation Methods
H

This approach breaks a molecule into
fragments and assumes that the total
LogP of a molecule is the sum total of all
contributions of each fragment. However,
the molecular environment affects the
contributions by each fragment. Hence,
correction factors are included in the
calculation as shown by the following
Fragments:
equation:

N

HO
O
N

quinidine

1 quinolinyl (-1H)
1 O (aromatic)
1 OH (aliphatic)
1 N (aliphatic)
where,
LogP =
a
=
f
=
bj
=
Fj
fragment

SUM
CH residual:

C11H18

log of the partition coefficient
SUM
the number of fragments,
Corrections:
fragmental constant
Proximity effect (+2CM),
frequency of Fj
th Electronegativity facing bulk (=
correction factor for the j
2CM),
O-C-Ar (+1CM)
LogP
A simple calculation by Rekker‘s
fragmental method is illustrated in the
panel at the right. The experimentally
determined value of LogP for quinidine‘s is
3.44.
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+1.617
-0.450
-1.448
-2.074
-2.355
+4.893
2.538
+0.438
-0.438
+0.219
2.757

Scheme 1.2 Atom contribution methods; the calculation of LogP for quinidine by
atom contributions is shown (adapted from Mannhold and van de Waterbeemd [18]).
Atom Contribution Methods
This is an extension of the fragmental
contribution method. It is assumed that the total
LogP of the molecule is a contribution by each
individual atom comprising it (instead of a
contribution by fragments). Calculation as shown
H
by the following equation:
where,
ni
= the number of atoms of type i
ai
= fragmental constant
A simple calculation by the Ghose / Crippen
method is illustrated in the panel at the right. The
experimentally determined value of Log P for
quinidine is 3.44.
Type
2
3
5
6
8
15
16
24
25
26
27
46
47
48
50
52
56
60
68
75

Description
C in CH2R2
C in CHR3
C in CH3X
C in CH2RX
C in CHR2X
C in =CH2
C in =CHR
C in R--CH—R
C in R--CR—R
C in R--CX—R
C in R--CH—X
H attached to C0sp3 with no X next to C
H attached to C1sp3 or C0sp3
H attached to C2sp3, C1sp3 or C0sp3
H attached to heteroatom
H attached to C0sp3 with one X next to C
O in alcohol
O in Al - Al, Ar2O, R:R or R-O-C=X
N in Al3N
N in R--N--R or R--N—X

N

HO
O
N

Quinidine
Frequency

-0.9748
-0.7266
-1.0824
-1.6740
-1.0420
-0.1053
-0.0681
+0.0272
+0.3200
-0.2066
+0.0598
+0.4410
+5.3488
+0.3161
-0.3260
+1.8475
+0.1402
+0.2712
+0.3954
-0.1106
LogP
2.852
Key symbols: R is group connected to C; X is heteroatom; ―=‖ is double bond; ―:‖ is an
aromatic single bond such as the C-N bond in pyrrole; subscripts give the hybridization
state and superscripts the formal oxidation number.
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2
2
1
2
2
1
1
4
2
2
1
1
16
1
1
5
1
1
1
1

Contribution

Hydrophobicity of amino acids and proteins – Understanding the hydrophobic
behavior of amino acids, peptides and proteins has implications far beyond the
seemingly simple task of calculating LogP for twenty or so small molecules (the amino
acids). Abraham and Leo extended the Hansch and Leo fragment-based method of
LogP calculation to amino acid zwitterions and side-chains [47].

Excellent agreement

was reported for 19 out of the 20 natural amino acids. Proline, however, was calculated
to be more hydrophilic than in reality, probably due to poor fragment parameterization
for its secondary cyclic amine. With this method, hydrophobicity values for amino acid
side chains were best predicted if a field effect was applied to the alpha-carbon. The
field effect is the sum total of polar proximity effects of both the backbone amidic
(peptide) bonds surrounding the alpha-carbon atom of any given residue. This field
effect parameter accounts for the charge distribution on side-chain atoms and hence
directly affects the hydrophobic/hydrophilic nature of the residue. Application of this
effect allowed a higher correlation between predicted and calculated values of
hydrophobicity for side-chains. In additional studies, Buchwald and Bodor reported a
correlation between the van der Waal‘s volume of peptides with their LogP values [48].
Another approach was adopted by Steinmetz, where 3-D QSAR Comparative Molecular
Field Analysis (CoMFA) studies were applied in a similar manner [49]. Experimentally
determined LogP values of free and blocked di- and tripeptides were analyzed
statistically to produce another set of parameters [50]. Akamatsu‘s work on the solvent
partitioning of peptides using regression analysis of the experimental data to abstract
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the hydrophobic parameters [51-54] is commonly regarded as the most convincing and
accurate [55]. A comparison between software programs in predicting peptide LogPs
was published recently [56].

In general, fragment-based methods are sensitive to

composition but not to peptide sequence, which can be considered to be a major flaw of
these programs. Also, it is important to note that most current programs are inefficient
and ineffective in calculating LogP values for long peptides.
Summary of LogP estimation methods – A lot of effort has gone into devising
methods for high prediction accuracy for LogP. However, most methods are accurate
for members or close relatives of their own training sets but continue to be less accurate
outside their training sets. It should also be pointed out that a considerable portion of
the predictive inaccuracy may in fact lie with the data itself. Such data has often been
obtained with experimental procedures whose accuracy varies with the method used
[57].

One example brings this into focus: as many drugs and drug-like molecules

contain ionizable functional groups, the conditions of measurement, particularly pH, are
extremely relevant to measured LogP. Thus, if a user attempts to estimate LogP for a
molecule, e.g., by specifying a carboxylic acid-containing species, what LogP value
should be reported?

The molecule in its acid form?

The molecule in its ionized

(nominally pH 7) form? Or the weighted average representing the equilibrium between
the two forms? (This is what the experiment, as performed on the molecules in the
training set, measures.)

As other functional groups on the molecule can shift that

equilibrium, how does this affect the contribution of the carboxylic acid/carboxylate
fragment (or constituent atoms) to the predicted LogP?
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While whole-molecule approaches are designed to estimate LogP values with
great accuracy without extensive piecemeal (atom- or fragment-wise) empirical
parameterization, their predictive nature in the end must also be compared to
experimental data, limiting our ability to really judge the accuracy of predictions. This
begs the question: do we need to emphasize accuracy of predictions so much? We
suggest that when it comes to drug design, it is largely the ΔLogP changes between
analogues that will drive the evolution in design with respect to physicochemical
properties of the molecule. Virtually all methods of estimating LogP can accurately
describe the replacement of a proton by a hydroxyl, the halogenation of an aromatic
ring, substitution of an amine for a methyl, or nearly any of the chemical modifications
that would be performed in fine-tuning a lead compound. The prediction of LogP for
random organic compounds is probably not an important real world exercise. Also,
representing such an important physicochemical property as a simple scalar value
underutilizes the information content of the molecule‘s 3-D topology and, particularly, its
hydropathic structure. The combination of topology and hydropathy provides us with
structural details of immense importance, which play a direct role in intermolecular
interactions, e.g., ligand binding, protein-protein associations, etc.

However, we do

recognize the importance of LogP in QSAR studies and also in assessing the drug
likeness of a compound, both of which will be discussed below.
Can predictive methods for estimating the LogP of a peptide translate into a
meaningful number for protein hydrophobicity? The idea that an additive atom-based or
fragment-based algorithm (or even a whole molecule approach) could describe the
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dissolution of a protein into water and/or 1-octanol is probably preposterous. To start, it
is likely that a severe conformational change would occur if macromolecules pass from
aqueous to organic solvents, e.g., hydrophobic residues would rearrange to the surface
while the hydrophilic ones attempt to optimize hydrogen bonding and/or electrostatic
interactions at the core.

In other words, a protein would be an entirely different

chemical species when interacting with solvents of different polarity – if it could actually
be solubilized. However, the atomic, fragment or residue-level components of such a
total LogP should be useful descriptors for understanding the forces and energetics of
protein secondary, tertiary and quaternary structure and have been used in various
schemes of describing and predicting protein folding for more than 20 years.
While proteins might change their conformation drastically on partitioning
between aqueous and 1-octanol phases, similar conformational changes are also
expected in small molecules. Such changes occur regularly for small molecules in both
aqueous and organic phases due to the comparatively lower energy barriers which
separate these conformations. However, it is not hard to imagine that organic phases
would stabilize conformations where intramolecular hydrogen bonds, ionic salt bridges
or dipole-dipole interactions exist because Coulomb interactions are strengthened in
these circumstances, while aqueous phases would stabilize those conformations which
show a higher degree of hydrophobic interactions. On the other hand, LogP is a selfcontained parameter which accounts for all such conformational preferences because it
is a bulk property and thus is the result of equilibrium between all such probable
outcomes.
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1.4 HYDROPHOBICITY SCALES AND PROTEIN FOLDING
There has long been evidence that protein secondary structure is dependent on
the hydrophobic properties of the amino acid residue side chains. There is, in fact, a
reproducible pattern of these properties in well-defined secondary structural elements
such as α helices and β sheets.

Thus, considerable effort has been expended in

developing hydrophobicity scales that can aid in predictions of protein folding patterns.
Some of these scales are based on water-ethanol transfer free energies [58,59], while
others are based on partitioning between the bulk aqueous phase and the air-water
interface [60], or on water-vapor partition free energies [61].

Kyte and Doolittle

discussed the weaknesses of all three of these in a paper that also introduced their own
hydrophobicity scale [62].

In their view, water-ethanol transfer free energy-based

methods suffer because some amino acids are known to be insoluble in both water and
ethanol and the latter may not be a truly inert solvent. Using partition data from transfer
between the aqueous phase and air-water interfaces was also problematical because
the hydrogen bonds that must be broken and the charges that must be neutralized to
remove a residue from the aqueous phase during the formation of the native structure
probably remain unchanged at an air-water interface. Thus, they would not be a factor
in the overall reaction.
The ―hydropathy‖ parameter of Kyte and Doolittle [62] is an amalgam of watervapor transfer free energies and the interior-exterior distribution of amino acid sidechains determined by Chothia [63].

A moving-segment approach that continuously

determines the average hydropathy while it advances through a sequence is used to
18

obtain a plot of hydropathy as a function of sequence. On this plot, any parts of the
sequence that are above the average hydropathy for the sequence are termed
hydrophobic and correspond well with experimentally determined ―internal‖ regions of
proteins.

Conversely, sequence elements with hydropathy below the average are

termed hydrophilic and correspond well with areas of the protein that are ―exterior‖ and
likely to be in contact with the polar solvent. The motivation is that analysis of these
data may indicate the ―folding‖ pattern of the sequence. To further exploit this, Wimley
and White reported a new forcefield derived from partitioning two series of model
peptides into the interface of neutral (zwitterionic) phospholipid membranes [64]. An
alternative approach was introduced in 1986 by Eisenberg and McLachlan [65] for
calculating the stability of protein structures in water based on atomic coordinates. The
contribution of each protein atom to the solvation free energy is estimated as the
product of the solvent accessibility of the atom and an atomic solvation parameter.
Li and Deber [66] used circular dichroism (CD) data to rank order helical
propensity of proteins within membranes. Residues such as Ile, Val and Thr, which
usually exist as -sheets in an aqueous environment, prefer an -helical conformation in
lipid membranes. Thus, the helical propensity of amino acid residues correlates with
the hydrophobic nature of the side chain. More recently, Dyson, Wright and Scheraga
have explained [67] how strict classification of side chains as polar or non-polar has
obscured certain facts about protein folding. For example, methylene groups present in
large polar or charged amino acid side chains, like the four methylenes in the lysine side
chain, can be considered non-polar. Interestingly, this fact was imbedded as one of the
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factors in the Hansch and Leo system for estimating LogP [68] nearly 30 years earlier!
These methylenes can aggregate with other non-polar groups and assist in hydrophobic
collapse of the sequence.
Felitsky et al. introduced the use of a new parameter called ―average area buried
upon folding‖ (AABUF) [69] that explains both local contacts and long-range
interactions.

AABUF was used to study folding of apomyoglobin and provided

additional insight into hydrophobic collapse and early folding events.

Studies on

polyalanine and polyleucine helices in water by MacCallum et al. [70] confirmed that in
folding many unfavorable enthalpic events are counterbalanced by favorable entropic
contributions by the solvent. This indicates a very small free energy barrier for folding.
Thus, folding is mainly a desolvation phenomenon. Similarly, the Mardia and Nyirongo
procedure for generating virtual protein Cα traces simulates the hydrophobic effect
during folding [71] and produces models that are globular and compact.
Another related application of hydrophobicity is in the development of algorithms
to simulate folding of hydrophobic-polar (HP) models in 2 and 3 dimensions [72]. The
concept is to simplify the complex problem of folding by reducing it to representing
residues by spheres with H (hydrophobic) and P (polar) character.

The ensuing

simulations are based on the observation that hydrophobic forces are the major forces
determining native conformation of small globular proteins. These model simulations
have been used to develop mathematical strategies for solving the combinatorial
explosion problem, rather than actually simulating the hydrophobic effect [73-74].
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As these studies have progressed over the past 20 years or so, the
understanding of the hydrophobic effect and its impact on protein structure has
matured. The early emphasis of using hydrophobicity scales to define folding patterns
has shifted to algorithms that define protein folding in terms of mathematical
approaches to reduce the calculational combinatorial explosion caused by exhaustive
sampling of conformational space. However, it must be repeated that the same forces
and energetics that drive solvent partitioning in the shake flask are at the core of protein
folding. The difficulty is to unravel them and define algorithms that can simulate folding
in these terms.
1.5 LogP IN DRUG DESIGN
Small molecule hydrophobicity has long been a consideration in drug discovery
and design.

The relationship between anesthetic effect of certain gases and their

hydrophobicity has been extremely well established [4,75,76]. As described by Meyer
in 1937 [3], chemically inert substances accumulate in ―lipoids‖ and at a certain
concentration, produce narcosis. The concentration itself is dependent on the animal,
but independent of the narcotic itself. Hansch et al. also confirmed the Meyer-Overton
hypothesis about a direct relation between hydrophobic nature of a compound and its
anesthetic capabilities [75] through statistical correlations. However, Hansch suggested
the additional involvement of a polar factor because molecules with polar hydrogens
showed greater anesthetic action. Hansch et al. also introduced a similar theory for the
hypnotic effect of barbiturates [76].

Other studies also have shown the important

correlation of partition coefficients with binding affinities of drugs to receptors [77,78].
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McFarland used a very simple probabilistic treatment of drug diffusion from the site of
administration to the site of action via a collection of hydrophobic and hydrophilic
barriers (Scheme 1.3, [79]). His relationship included a ratio for the rates of permeation
for drugs between aqueous and organic phases (k/l) which relates to the partition
coefficient at equilibrium. Inclusion of the Hammett equation into this study gave an
intuitively satisfying parabolic relationship between drug potency and hydrophobicity
(Scheme 3): higher doses of drugs with unfavorable partition coefficients (either too high
or else too low) are required for them to reach the site of action. Recently, Kier has
proposed a general theory of inhaled anesthetics [80].
1.5.1. The Lipinski “Rule of 5”
Hydrophobicity, of course, has also been a key factor in Lipinski‘s ―rule of 5‖
[81,82]. In simple terms, Lipinski‘s rule can be stated as such: Poor absorption or
permeation is more likely for a chemical entity when: a) there are more than 5 H-bond
donors (sum of OHs and NHs); b) the molecular weight is over 500; c) the LogP is over
5; or d) there are more than 10 H-bond acceptors (sum of Ns and Os). The only
exceptions to these rules were said to be substrates for biological transporters and
natural products, which have a tendency to be highly complex molecules with multiple
stereogenic centers and rarely contain nitrogen [83,84].
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Scheme 1.3 A parabolic relationship exists between drug potency and
hydrophobicity. McFarland‘s equation relating probability and partition coefficient [79].
Model of n alternating aqueous phases and lipophilic membranes, in a hypothetical
biological system is shown below:
Aq0 Lip1 Aq2 Lip3
Aq4…………………………………………Lipn-2
Lipn-1 Aqn
Assume that the rate of passage of molecules from aqueous to lipophilic zones is k,
while the rate of passage of molecules in the opposite direction is given by l. Then, the
partition coefficient of the molecule will be given by k/l.
If Px,y is the probability of moving a molecule from layer x to layer y, the probability of
moving a molecule from aq0 to aqn is given by:
Although passage of molecules would actually be affected by a number of factors,
unbiased passage of the molecule is assumed here. This reduces the entire problem to
one of pure probability. So, we will have:
Similarly, the following equation can also be obtained:
Combining all three above equations, we have:
Now, the number of molecules being transferred from aq0 to lip1 is proportional to k.
The total number of molecules is proportional to the sum of k and l. The probability of a
molecule moving from layer 0 to 1 is given by P0.1, which is mathematically defined as:
Dividing both numerator and denominator on the right hand side by l, we get:

If P1.0 is the probability of a molecule passing from lip1 to aq0,
Since we have assumed equal probabilities, we have:
Substituting this equation into the fourth equation described above, we have:

This relationship will be parabolic, indicating that there is an optimum range of LogP
with respect to drug potency.
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In 2000 Lipinski introduced changes to address terms such as ‗drug-like‘
because it was predicted that ADME (Absorption, Distribution, Metabolism and
Excretion) screening of molecules (into drug-like or non-drug-like) would precede
screening for activity at biological receptors [82]. The rule of 5 was further extended
[85] to define a number of useful parameters: a) the presence of greater than 10
rotatable bonds reduces oral bioavailability; b) 0 < LogD < 3 enhances the probability of
good intestinal permeability (LogD is logarithm of the distribution coefficient D, which is
in turn defined as the ratio of the sum of concentrations of all forms, whether charged or
neutral, or different functional conformations of the substance distributed between two
mutually immiscible phases); c) a polar surface area (PSA) of less than 60-70 describes
CNS active compounds; d) an N+O count of less than or equal to 5 enhances the
probability of passing the blood-brain barrier; e) if LogP – (N + O) > 0, the molecule
tends to be CNS active; f) orally-active drugs have lower molecular weight and fewer Hbond donors, acceptors and rotatable bonds; g) pulmonary drugs tend to have a larger
PSA; and h) if the molecular weight < 300, LogP < 3, H-bond donors and acceptors < 3
and rotatable bonds < 3, the compound can be called ―lead-like‖.
This revolutionary work, which brilliantly summarized over 100 years of Medicinal
Chemistry trial and error, made possible a number of rational filters and screens that, in
principle, would improve the likelihood that a compound with promising ―activity‖ could
produce a ―lead‖ and eventually yield a ―drug‖. Muegge described various methods for
classification of drug-like compounds in his 2003 publication [86]. Similar publications
addressing the terms ‗drug-like‘ and ‗tool-like‘ were also made [87,88]. Oprea et al.
24

reported the presence of a ―medicinal chemistry lead-like space‖ and urged careful use
of Lipinski‘s rules [89]. A very interesting discussion [82] on how the properties of drug
candidates from two pharmaceutical companies have varied across time pointed out
that stress on rational methods of drug design in Merck laboratories caused no
significant change in MLogP (Moriguchi LogP [90]) values across time. In contrast,
there was a measurable increase in MLogP values for candidates from Pfizer since
almost 50% of their hits were discovered with high-throughput screening (HTS)
methods. Because the easiest method to increase in-vitro potency is to appropriately
position a hydrophobic moiety onto a lead compound, HTS methods almost invariably
select more hydrophobic candidates. Similar trends were observed [91] in that more
than half of the molecules reported to have high-activity towards the end of the last
century had a high LogP (> 4.25), high molecular weight (>425) and log of solubility in
its neutral state (estimated from its molecular weight and LogP values), i.e., LogS w (< 4.25), only about 35% of the true lead compounds had these properties. It was also
noted that as these molecules go through clinical trials, there is a distinct decrease in
LogP values for compounds that make it to the market. One thing is clear from these
studies and an analysis by Proudfoot of drugs currently on the market [92]: the
lipophilicity of molecules that make it all the way to commercialization has remained in
the same range for a number of years. In other words, there is a delicate balance
between the hydrophobic and hydrophilic nature of a molecule that is absolutely
essential for it to be transported to the site of action by diffusion across membranes.
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1.5.2 Hydrophobicity in QSAR
Similarity between molecules is often perceived by chemists both qualitatively
and quantitatively. A synthetic chemist would describe two molecules as similar if they
have similar topologies, bond connectivities, functional groups or maybe synthetic
strategies. Structure-Activity Relationships (SARs) are based on such comparisons in
the context of physiological function, but are mostly limited to qualitative or semiquantitative treatments of biological phenomena or activities. However, more stringent
definitions of similarity have been formulated and can be used with chemical computing
software to perceive (and even predict) chemical equivalence provided the likeness is
scrutinized critically. Thus, a more mathematical and quantitative approach called the
Quantitative Structure-Activity Relationship (QSAR), wherein affinities of ligands for their
binding sites, inhibition constants, rate constants and other biological activities are
correlated to molecular properties such as lipophilicity, polarizability, electronic and
steric properties, was developed. Comprehensive reviews have been published on the
subject in the past [93,94], which should be referred to by those wishing to learn about
the QSAR concept in depth. Here, we will focus on the key role of hydrophobicity in
these studies.
There are many different approaches used in classical QSAR studies, including
establishment of relationships between activity and physicochemical properties such as
steric properties (Hansch analysis, extrathermodynamic approach), structural features
(Free Wilson analysis) [94], or topological descriptors (Kier-Hall indices) [42]. 3D QSAR
methods, especially those such as CoMFA, consider three-dimensional ligand
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structures and use those to propose the binding modes of those ligands at a common
protein active site [94]. Data is often analyzed by statistical methods such as Multiple
Linear Regression (MLR), Partial Least Squares (PLS) or by use of artificial intelligence
(AI) methods such as Neural Networks (NN) or Support Vector Machines (SVM) [95] in
order to detect correlations between a target activity and various descriptors (like LogP).
Hansch and Fujita first introduced their method and coined the term QSAR, for
correlation of biological activity to chemical structure in the 1960s [78,96-98].

The

method correlated, by the use of regression analysis, ligand structural variations with
the biological activities of those ligands. In time, these studies would become a distinct
scientific field and a mainstay of drug discovery and design research.

Many

applications have been reported across the past five decades. A review by Kubinyi has
described, in great detail, the various subtleties of the science [99]. Indeed, in the
absence of a detailed target or receptor structure, this ligand-based drug design method
gives invaluable quantitative information to drug designers. It is important to note that
the first publication on QSAR in 1962 [78] showed the importance of hydrophobicity
through LogP. Scheme 1.4 explains the general concept behind the Hansch Analysis
technique where the free energy-based substituent constant  is based on the Hammett
function . is dependent on the substituent‘s chemical nature and, since molecules
must repeatedly partition between lipid membranes to be effective drugs, the
constituting fragments of should be such that their additive effect would allow easy
partitioning into either membranous or aqueous phases.
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Scheme 1.4 Hansch Analysis; a method to relate physicochemical parameters to drug
potency. For details, refer to Hansch and Fujita [95].
The ‗extrathermodynamic approach‘ relates various free energy-like descriptors in a
model:
(C, LogP and σ are the inhibition constant, log of the partition coefficient and steric
parameters respectively, while a,b,c and k are constants.) This model explains that drug
transport from site of application to the site of action depends on the lipophilicity of the
drug and is non-linear under typical conditions. Although special conditions could
reduce this equation into simpler forms [73], this equation surmises the behavior of any
molecule under normal diffusion conditions.
A novel parameter π defines the lipophilicity of substituent X:

where LogP is the log of the partition coefficient. This equation was a variant of the
Hammett Equation,

where the reaction equilibrium constants have been substituted with partition
coefficients.
Values for LogP and σ of different molecules may be correlated with their IC50 or Ki
values by statistical analysis such as multiple linear regressions (MLR) or partial least
squares (PLS). Artificial intelligence methods such as Neural Networks (NN) and
Support Vector Machines (SVM) have also been used. These analysis methods have
pros and cons: While MLR and PLS do a good job of finding linear relationships
between variables, they tend to oversimplify. On the other hand, artificial intelligence
methods tend to pick up on minute non-linear trends and tend to over-fit models.
It must be noted, however, that hydrophobicity is not always the principal
parameter determining activity [100]. For example, when DNA is the drug target, e.g., in
binding to the major or minor groove, QSAR analyses often show negligible
hydrophobic terms because the negatively charged phosphate groups of DNA are
hydrophilic. On the other hand, DNA intercalation would likely be a hydrophobic effect.
Radical reactions also typically lack hydrophobic terms in QSAR analyses, although
these studies are mostly on small datasets and more thorough studies would be
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desirable.

Finally, it has been suggested from QSAR studies on Multiple Drug

Resistance that this process might be accomplished without hydrophobic assistance,
although this conflicts with the fact that efficiency of efflux pumps is often correlated with
the hydrophobicity of their substrates [101].
3D QSAR methods like Comparative Molecular Field Analysis (CoMFA) [102]
generate 3D field maps around aligned molecules to display zones of steric, electronic
and lipophilic tolerance or intolerance. This gives a visual understanding of biological
activity that contrasts well with the often messy collection of molecular descriptors in
classical QSAR studies, thereby allowing easier interpretation of results. This, in turn,
may lead to a better basis for designing novel scaffolds and/or chemical substituents to
the existing scaffold.

The basic idea behind this method is explained in Figure 2.

Kellogg et al. introduced a method for hydrophobic field calculation for CoMFA [103]
using an empirical force field (Hydropathic INTeractions or HINT, discussed in Section
1.7). This was one of the first attempts in 3D QSAR to modify the purely enthalpic
treatment of ligand-receptor binding by inclusion of an implicit entropic term.
References to the use of HINT-CoMFA in drug design are available [103-106]. Another
attempt to include hydrophobicity into CoMFA was made by Gaillard, Testa and
coworkers in their papers [107,108] describing the use Molecular Lipophilicity Potential
(MLP) in 3D QSAR along with its applications.

This alternative method of using

hydrophobicity in CoMFA studies has found a number of applications in molecular
modeling and drug design work [109-111].
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Molecules are overlapped and placed in a grid, which is spread all around the
overlapped molecules up to the extent of several Angstroms in all directions. Each grid
point is treated as a probe; neutral Carbon atoms are used as probes for van der Waal‘s
interactions, while charged atoms can be used as Coulombic interaction probes. Groups
can also be used as probes, especially when trying to elucidate H-bond donors or
acceptors. Simple physics equations for interactions of different varieties can calculate
energy of each grid point, thereby extracting data for analysis. This data can then be
checked for trends using PLS, MLR or AI algorithms.

The resultant map, shown above, is a map of regions where certain physicochemical
parameters are tolerated (or not tolerated), which serves as an aid to chemists.
Figure 1.2 3D QSAR; 3 Dimensional Quantitative Structure Activity Relationships (3D
QSAR) are models generated by taking into account the 3 dimensional positions of
various physicochemical characteristics of a set of overlapped molecules and the effect
they have on drug potency. Refer [71] for details.
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1.6 QUANTIFICATION OF HYDROPHOBIC INTERACTIONS
Equations calculating energy from structure, a.k.a. force fields, have been in use
for many years in computational chemistry and molecular modeling [112]. Generally,
force fields have been restricted to enthalpic terms that are simple to correlate with
bond formation or bond breaking and simple Newtonian physical phenomena like bond
stretches and bends, electrostatics and dispersion. The hydrophobic effect is, in some
measure, an entropic phenomenon and is not easily derivable from these first principles.
Nevertheless, a few examples of quantifying lipophilicity and its effect on biomolecular
energetics have been reported [12,113-119]. Hermann and Chothia [12,113], among
others, proposed that hydrophobicity can be quantified by the calculation of hydrophobic
surface area. Oobatake and Ooi present an excellent review of this approach [114].
Cramer and Truhlar introduced a solvation model [115] that included charge
distributions on solute molecules, the energetic effects of cavity formation and
restructuring of water around such cavities and even subtle variations in charge
distribution due to interactions between solute particles and surrounding solvent
molecules. Sharp and coworkers introduced a new solvation model illustrating the
dependence of the hydrophobic effect on curvature of the site [116].

This was an

attempt to explain the difference between the calculated energy for hydration of
hydrocarbons (about 25 cal mol-1 Å-2) and the surface tension at the water-hydrocarbon
interface (about 75 cal mol-1 Å-2). This altered surface area measurement suggested
that the ―macroscopic‖ hydration energy is 47 cal mol-1 Å-2. Indeed, the assumption that
the energy of hydrophobic interactions is dependent on the area of the hydrophobic31

water interface is the mainstay of much research in the area. However, alternative
approaches have had some success. Cesari et al. presented a model describing the
hydrophobic interactions within globular proteins based on analysis of X-ray data [117]
where fold definitions were clearly shown to be a function of hydrophobicity. Hummer
described the development of a hydrophobic force field as an alternative to surface-area
models [118]. A highly developed model for quantitating hydrophobic interactions is the
HINT (Hydropathic INTeractions) system that is discussed below.
1.7 THE HINT PARADIGM
A notably different approach was taken by Kellogg and Abraham [119,120] in designing
the ―natural‖ force field HINT (see Scheme 1.5). This non-covalent interaction force field
is derived from partition coefficients based on the Hansch and Leo LogP estimation
method. It is very empirical in nature and approximates all components of biomolecular
interactions, including hydrogen bonding, Coulombic interactions along with entropy and
solvation/desolvation effects in addition to hydrophobic interactions because all of these
effects are inherent in the experiments that measure LogP [68].

Interestingly, the

Hansch and Leo method encodes many interaction effects within the ―correction‖
factors. For example, intramolecular hydrogen bonding within a small molecule, which
would make the molecule less polar (and seemingly more hydrophobic) because the
involved polar hydrogen and its partner acceptor are less able to interact with water
solvent, is encoded with a factor that gives an internally calibrated indication of the
energetics of hydrogen bonding (0.6 – 1.0 LogP units, i.e., 0.8 – 1.4 kcal mol-1).
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Figure 1.3 HINT map for the molecule of tyrosine. This map shows a hydrophobic
area on the molecule represented as a cage around the benzene ring. The polar areas
on the map are further depicted: acidic (light grey lobes) and basic (dark grey lobe).

33

Scheme 1.5 The HINT Paradigm. A ―natural‖ free energy force field based on LogP. It
is available as a toolkit, allowing flexibility in development of applications. Refer to
Kellogg and Abraham [118] for details.
By definition,

LogP can be considered the sum total of individual
lipophilic propensities of each atom called hydrophobic
atom constant (ai), i.e.
The values of ai are readily available from various
methods, as described earlier; HINT itself uses an
adaptation of the Hansch and Leo C-LOGP approach [2327]. The HINT method calculates scores (bij) of each atom
against all other atoms according to the equation

A representation of a
shake flask. Substances
distribute
themselves
between the water and
octanol
layers
with
concentrations Cwat and
Coct, respectively, in a
particular ratio called the
partition coefficient.

Where, ai is the hydrophobic atom constant for the ith atom
and Sij is the solvent accessible surface area. T ij is a
variable which takes on the values of +1 or -1, depending
on the acid and base properties of the pair of atoms being
considered. For example, if the atoms under consideration
are both amino nitrogens, the interaction is unfavorable
and Tij is -1. In contrast, if one is a polar (amine) hydrogen
and the other is a carboxyl oxygen, their interaction would
be favorable and Tij is +1. Rij is the exponential term e-r,
where r is the distance between the i and j atoms. r ij is a
van der Waal‘s term.
The total HINT score would be the sum total of each atomatom score thus calculated, i.e.

If G is the change in Gibb‘s Free Energy, R is the gas constant and T is the absolute
temperature,
we know that
and
;
thus,
.
Hence, HINT scores reflect free energy by taking into account both enthalpic and
entropic factors. Because the absolute value of HINT score may not be predictive of a
discrete biological association event, these absolute scores are not as important or
relevant as differences in HINT score values between analogous systems, much the
same as differences in free energy, i.e., ΔΔG. The difference in Gibb‘s Free Energy
between two states is a very important parameter as it tells us about the spontaneity or
likelihood of the change, whereas the value for any one state itself is often of less
consequence.
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A key principle behind HINT is that significant understanding of biological phenomena,
particularly interactions, can be revealed by representing hydrophobicity as a 3D ―field‖
property rather than as a simple scalar (number) [121]. For example, consider the
tyrosine molecule shown in figure 3. Hydropathic properties of the molecule are mapped
in three dimensions around the structure of tyrosine, creating a HINT map. The use of
these maps creates a visual representation of properties that are often mentioned
casually, such as hydrophobic or polar nature of functional groups. Not only does this
methodology allow a chemist to form a qualitative understanding of the molecular
topology, but also forms the basis for quantitative estimation of physicochemical
properties by using the HINT force field. This may further be used in the depiction of
molecular interactions, which has a direct repercussion in drug design.
1.7.1 Intermolecular Interaction Analysis
Perhaps the most important application of HINT is in the assessment of
intermolecular interactions.

HINT calculations derive an interaction score that in

numerous studies [122-125] has been shown to correlate with free energy of interaction.
Although it is data set dependent, i.e., for specific protein-ligand or polynucleotide-ligand
systems, it is estimated that on average, 515 HINT score units correspond to 1 kcal mol 1

free energy of binding [119]. A recent report indicated the value of the HINT score in

ligand docking studies by a comparison to the scoring functions within FlexX, AutoDock
and GOLD [123]. The most important advantage of the HINT methodology is that it
inherently estimates enthalpic as well as entropic contributions to binding (Scheme 5).
It has been shown [122,126] that errors in prediction for very diverse sets of protein35

ligand complexes are approximately ± 2.6 kcal mol-1, although within a family of ligands
binding to the same protein this error can approach ± 1 kcal mol -1. There often is an
order of magnitude difference between values of Ki measured by different laboratories
on the same protein-ligand complex, which corresponds to a possible 1.0-1.5 kcal mol-1
experimental uncertainty. Thus, the error value reported above between experimental
results and HINT scores indicates that HINT is a robust method for binding affinity
predictions.

Further sources of error include uncertainties in positions of atoms in

models, incorrectly assigned atom types, or (often) missing solvent molecules in the
source crystallographic structure data. The HINT method has been used successfully in
quite a number of projects [122,126-129]. In a recent example, Tripathi et al. generated
a model capable of predicting antiproliferative activity of pyrrole derivatives against
cancer cell lines.

In this study, experimentally determined IC50s of a number of

compounds were correlated with HINT scores from docking these ligands to αβ-tubulin
to generate molecular models that could be scored and yielded a significant correlation.
This correlation could distinguish active molecules from inactive ones by the HINT score
value and, thus, provides a basis for design of novel molecules with anticancer activity.
In another interesting application the sequence specificity of anthracycline groovebinding intercalators was evaluated and predicted by HINT score [130]. This work
illustrated that the HINT score could be parsed into relevant free energy subsets that
can be ranked and compared for particular intercalator functional groups and/or
nucleotide bases in DNA double helix strands.
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1.7.2 Computational Titration
An extension of the HINT force field known as Computational Titration [124] is
used to evaluate the ionization states of functional groups on ligands or residues at the
binding site. It is well known that these variations can have a strong influence on
binding affinities. The method models, in parallel, multiple ionization states for both
ligand and protein creating a collection of ionization state ensembles. Each distinct
protonation state ensemble is optimized for hydrogen bonding, including water positions
and analyzed by HINT score. The best scoring complex indicates the optimum state for
binding and suggests the corresponding pH for that optimum binding. However, the pH
at which crystals are grown and analyzed can be different from this optimum pH. The
resulting model can help reconcile the differences between in silico models and data.
However, at room temperature, where binding data is measured, there are likely to be
many protonation models of similar, accessible energy.

Computational Titration

analysis helps develop an understanding of the relationship between these states.
There

is

now

a

computational

titration

server

for

public

use

at

http://hinttools.isbdd.vcu.edu/CT [131].
1.7.3 Analysis of Bridging Waters
Another factor relating to the stability of biomolecular complexes is the
contribution of water molecules within the binding site and bridging between the ligand
and biomolecule [125,132]. The presence of these bridging water molecules can be a
very important factor in binding of molecules, but water molecules can play a variety of
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roles as they facilitate biomolecular interactions and stabilize structure. Often, due to a
variety of experimental reasons, positions of water molecules in crystal structures are
not well defined, even after x-ray crystallographic analysis. This mischaracterization and
non-detection of water positions can be correlated with x-ray crystallographic resolution,
with better resolution both locating a larger number of water molecules and placing their
positions more accurately. Thus, to thoroughly evaluate structure, it is often necessary
to verify water molecules systematically with tools such as the GRID program of
Goodford [133].

Concomitantly, it is desirable to know which of these waters are

subject to displacement by ligands and which are conserved.

Using HINT score

combined with a metric based on geometry, Amadasi et al. developed a robust method
to calculate the relevance of binding site waters; those with particularly high relevance
score would be expected to yield extra entropy if a ligand was designed to displace it,
i.e., similar to the cyclic HIV-1 protease inhibitors [134].

In another study, the

contribution of bridging water molecules to overall free energy of binding has been
derived and quantitated [132].
1.7.4 3D QSAR with HINT
A very early application of the HINT force field was the introduction of field
hydrophobicity parameters into 3D QSAR technology, to complement the original steric
and electronic fields in CoMFA [103]. The steroid data set originally reported by Cramer
et al. [102] was reexamined with the addition of a HINT-derived field. While this study
provided little advantage in terms of statistical improvement due to a variety of reasons
described previously [119], it provided a distinct advantage in chemical interpretability
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for chemists aiming to design new molecules based on such a QSAR study. Quite a
few reports of studies based on the HINT-CoMFA methodology have been reported
since then [104-106,135-140] and some, particularly where the ligands or active sites
are particularly non-polar, do show significant statistical improvement when hydrophobic
fields are included. Fields in 3D QSAR are another class of descriptor that often needs
to be optimized for the data set [141] in that each data set has forces and structures that
may be best represented hydrophobically, sterically, electrostatically, or with other types
of fields.
1.8 AIMS AND OVERVIEW OF WORK
The overall aim of computational chemistry is manifold: (1) to develop bioactive
agents, (2) to help understand and quantify complex biological phenomena and (3) to
develop tools that aid in computational exploration of biological interaction events. The
major tool used by us in order to achieve all three objectives is the HINT forcefield.
Herein, we employ our in-house computational tools (HINT and the HINT Toolkit), which
are an amalgamation of experimental and theoretical methods to explore biological
functions of molecules and discover biologically active agents in this work. We also
outline strategies to enhance already available computational tools here.
As described earlier in the chapter, the HINT paradigm has been successfully
applied in exploring biological phenomena, particularly in binding of macromolecules
and also in drug design (vide supra). In most projects reported thus far in literature, the
HINT forcefield has been applied to simple binding phenomena, i.e. interactions
between macromolecules or those between a drug and its target. Given this fact, we
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asked ourselves whether it is possible to explain complex biological phenomena (such
as transporter-facilitated molecular efflux) in terms of hydropathic interactions using the
HINT forcefield. In other words, our hypothesis is that HINT can explain proteinmediated molecular transport in terms of successive, but independent binding events?
One major field of interest for us is to explore new avenues and develop tools for
exploration of chemical space in an attempt to simulate the motion of proteins during
their interaction with ligands and its application in drug design. In accordance with this
aim, we commenced a project to explore the compatibility between existing knowledgebased databases of amino acid residue sidechains and the HINT scoring function. The
major aims of this project were to set up grounds for the development of a novel
algorithm that will assist in simulation of partial active site flexibility. With this in mind,
we hypothesize that HINT can address intramolecular interactions as well as
intermolecular ones.
Herein, chapter 2 describes different approaches adopted in order to predict
efflux of antibiotic substrates by the AcrA-AcrB-TolC efflux pump. A 3D-QSAR study of
efflux yielded ostensibly predictive models, which were validated within a dataset
obtained from literature. An alternative methodology was designed due to the inherent
problems of 3D-QSAR, which have also been described. This alternative method led to
interesting quantitative predictions of high/low efflux for substrates.
Chapter 3 describes a virtual screening approach towards identification of agents
which inhibit hemagglutinin-neuraminidase (HN) of human parainfluenza virus type III
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(HPIV3). The current status of this project is discussed therein, along with problems with
sidechain placement during the docking process.
The following chapter expounds early attempts at development of a sidechain
optimization algorithm aimed at creating a basis for the development of improved
docking simulation tools in the future. The current status of the algorithm, along with
future directions, is delineated.
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CHAPTER 2
PREDICTING EFFLUX OF ANTIBIOTICS BY ACRA-ACRB-TOLC PUMPS:
A ‗SYSTEMS HYDROPATHY‘ APPROACH.

2.1 Introduction
Antimicrobial drugs have been crucial tools of healthcare for decades due to their
effectiveness in control of bacterial infections. However, soon after their discovery it
was realized that some pathogens rapidly developed resistance to antibiotics [1,2].
Initially, this problem was overcome by discovery of new classes of antibiotics such as
aminoglycosides, macrolides and glycopeptides, but it soon became clear that bacteria
had an impressive array of defensive mechanisms that conferred on them, resistance to
many modes of attack [1]. Organisms that cause pneumonia and cutaneous infections,
Streptococcus pneumonia, Streptococcus pyogenes and staphylococci, are now
resistant to almost all of the older, first generation, β-lactam antibiotics [2] like penicillin,
which were discovered through screening of mold samples and act in general by
mechanically weakening cell walls and making them susceptible to osmotic lysis [3-5].
Members of the Enterobacteriaceae and Pseudomonas families, which cause diarrhea,
urinary infection and sepsis, are also resistant [2].

The development of bacterial

resistance to antibiotics has mostly been attributed to their excessive use in the clinic as
well as at home [1,2]. However, semisynthetic modifications of β-lactam antibiotics
have given us second- and third-generation antibiotics that have prolonged the
therapeutic usefulness of the drug class.
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One primary mechanism of antibiotic resistance is extrusion of the foreign chemical,
which is termed efflux.

In 1980, it was reported that tetracycline could be actively

effluxed from the bacterial cell [6]. Since then, many efflux-related mechanisms have
been discovered.

Efflux pumps are transporters involved in extrusion of toxic

substances from cells, thereby limiting the detrimental effects of these substances [7].
They may be substrate-specific and responsible for transporting biological compounds
such as bile salts, or may be promiscuous and transport structurally-diverse compounds
such as various classes of antibiotic drugs [8]. Overexpression of these structurally
complex and versatile proteins may thus lead to antibiotic resistance. While efflux pump
proteins are present in both Gram-positive and Gram-negative bacteria and also in
eukaryotes, antibiotic resistance due to efflux is more of a problem in Gram-negative
bacteria than in Gram-positive bacteria [9]. This is due to the presence of an outer
membrane

in Gram-negative

bacteria

that demonstrates comparatively

lower

permeability and complements the efflux activity of these pumps.
Several such pump systems have been described: Campylobacter jejuni (CmeABC)
[10-11], Escherichia coli (AcrAB-TolC, AcrEF-TolC, EmrB, EmrD) [12], Pseudomonas
aeruginosa (MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY-OprM) [12],
Streptococcus pneumonia (PmrA) [13], Salmonella typhimurium (AcrAB) [14] and
Staphylococcus aureus (NorA) [15]. These pumps basically fall into five major families,
including the MF (major facilitator), MATE (multidrug and toxic efflux), SMR (small multidrug resistance), ABC (ATP-binding cassette) and RND (resistance-nodulation-division)
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families [16]. It has been shown that co-expression of multiple types of efflux pumps
can cause an additive or even multiplicative effect on drug resistance [17].
AcrAB was first described as an efflux system in 1995 [18]. AcrB is responsible for
efflux of bile salts, thus protecting enteric E. coli from the detrimental effects of these
powerful detergents [19].

As is typical with other members of the RND-type efflux

protein systems, AcrAB is also a proton antiporter.

AcrA and AcrB homologues in

Haemophilius influenzae HI0894 and HI0895 respectively, are also responsible for drug
efflux [20]. The importance of AcrAB in multidrug resistance has been described in
several publications, [21-27] where knock-out, knock-in and mutation studies were used
to describe the extent to which the AcrA-AcrB-TolC transporter is responsible for
expulsion of structurally diverse antibiotics from bacterial cells.
One important observation from all these studies was that efflux pumps seem to
preferentially extrude hydrophobic ligands [24]. However, despite extensive studies on
the efflux of antibiotics by the AcrA-AcrB-TolC efflux pump, reliable and generalizable
predictions for efflux by this pump continue to be elusive.

Such predictions would

obviously be of tremendous interest to those engaged in design/discovery of antibiotics,
as this would allow them to more efficiently channel effort and resources. Interestingly,
despite the tremendous importance of efflux as an ancillary consideration in drug
discovery, very few computational studies designed to predict the effect on proteins
other than P-glycoprotein [28-30] have been reported.

However, two-dimensional

quantitative structure-activity relationship (QSAR) studies performed previously [31,32]
yielded what appeared on the surface to be remarkable regression equations for efflux
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of β-lactam substrates by the AcrA-AcrB-TolC pump from Salmonella thypimurium (16
compounds, target: minimal inhibitory concentration for three strains, reported r2 from
cross validation (q2) > 0.9). No surprising conclusions were made in this study, i.e.,
molecules showing more hydrophilic character, including hydrogen bonding capability,
were likely to be poor efflux substrates and that efflux correlated with properties like
LogP (for partitioning the drug between 1-octanol and water), the y-axis component of
electrostatic dipole moment, the surface area of hydrophobic carbons, the number
fractions of carbons and heteroatoms and the number of charged groups and the
number of nitrogen and sulfur atoms, all of which would supposedly influence
interactions between pump and substrate [31]. However, the number of descriptors in
the equations (up to 9) suggests serious overfitting of such a small data set and the
inclusion of multiple methods of LogP prediction within the same QSAR equation is also
a concern: while LogPs calculated by different methods do not necessarily encode
exactly the same information about a molecule, they must be largely correlated and
some of the other descriptors, e.g., surface area of hydrophobic carbons, also likely
correlate with LogP. Most importantly, it does not appear that this type of model has
been embraced by potential users of efflux prediction in drug design, possibly because
of its poor chemical and physical interpretability.
In the present contribution, we describe a computational modeling method that
allows us to successfully identify the extent of efflux of individual ligands by taking into
account interplay between properties of the ligands as well as their molecular-level
interactions with the AcrA-AcrB-TolC efflux pump. Although an initial 3D-QSAR study
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produced seemingly predictive models for the β-lactams, we decided to ―invent‖ a new,
largely intuitive method based on what is known about efflux and found a successful
prediction of efflux values for a structurally diverse dataset, composed of both -lactam
and non--lactam antibiotics. Our approach holds a superficial similarity to the ‗systems
biology‘ approach, where the effects of a factor on multiple pathways are taken into
account by compartmentalization in order to explain observed gross phenomena and
we are thus calling our method ―systems hydropathy‖ (vide infra). It is also interesting to
note that our results suggest certain novel mechanistic details of efflux, hitherto
untested and unreported.
We further propose that this method may be extended to several complex
transporter systems such as the ABC proteins, which are suspected to cause resistance
to anticancer drugs [33].

2.2 EXPERIMENTAL SECTION
2.2.1 Crystal structures of AcrB and TolC.
The crystal structures of AcrB and TolC (PDB codes 2drd and 1ek9 respectively)
are available in the RSCB database [34,35]. The protein structures were modeled using
Sybyl version 8.1 (Tripos International) [36]. Hydrogens were added, followed by 1000
steps of Powell minimization with Gasteiger-Hückel charges while keeping the heavy
atoms still. Then the entire structure was minimized to a gradient of 0.005 kcal mol-1 Å-1.
Visual inspection revealed no unrealistic steric clashes between residues.
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Where

required, the ligand was removed from the protein binding state (from PDB code 2drd)
to void the docking region.
2.2.2 Efflux data and substrate molecules.
A review of literature produced a curated set of 32 β-lactam antibiotics (Scheme 2.1)
and 12 non-β-lactam antibiotics (Scheme 2.2), for which efflux data has been reported
[23-25,27,37]. This data was in the form of minimum inhibitory concentration (MIC)
ratios (i.e., ratio of MIC in the presence of efflux pump to the MIC in the absence of
efflux pump through knockout). All reported MIC ratios for these compounds were
taken and an average MIC ratio was obtained. Because the experimental data are
reported as powers of 2, i.e., 1, 2, 4, 8, 16, etc., logarithms (base 2) were calculated for
these average MIC ratios and these logarithmic values were used as the dependent
―efflux‖ parameter in our analyses (Table 2.1). The range of MIC values for wild type
(WT) pumps across all sources is also reported here. The narrow range of WT MIC
values for each antibiotic clearly indicates that similar if not identical pump strains were
used during experimental procedures reported in these referenced works such that
these MIC ratios are directly comparable.
As all of the substrate antibiotic molecules have acid and/or base functionalities, the
structures were modeled in Sybyl in both their neutral (non-ionic) and charged (usually
zwitterionic) forms and minimized to a gradient of 0.005 kcal mol-1 A-1. An attempt was
made to initially place each compound in its lowest energy conformation by manually
selecting from available rotamers.
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Scheme 2.1. Chemical structures for the -lactam antibiotic compounds in the study.
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2.2.3 Docking and scoring.
The initial methods development for this study was performed with only the β-lactam
ligand set (Scheme 2.1) and then applied to the full, extended dataset. All compounds
were docked in both their neutral and charged forms using GOLD version 3.0 [38].
When docked to different parts of the TolC cavity (see Figure 2.1 and Results and
Discussion for further description), 100 positions for each compound in Scheme 2.1
were obtained at each of eleven different overlapping areas of the protein, giving us a
total of 1100 solutions per compound. However, a total of 2000 positions were obtained
per compound when docked into the binding state or extrusion state of AcrB. The
antibiotics in Scheme 2.2 were docked at four different positions as selected by the
model found for the β-lactam compounds (see Results and Discussion), using identical
procedures and parameters. All docked positions were scored using the Hydropathic
INTeractions (HINT) forcefield [39-41] as reported in previous work [42-43]. The HINT
forcefield has been previously shown to not only estimate enthalpic contributions
towards binding but also entropic and solvation contributions [39-43]. The pose
corresponding to the highest HINT score for each ligand at each position was selected
for further analysis. GOLD scores were ignored because the software is known to fail for
hydrophobic systems [38]. The best docked positions were combined into protein-ligand
structures that were minimized with 500 iterations. The interactions were re-scored at
the minimized positions and these HINT scores were used as descriptors. Further
explanation regarding application of the various HINT scores as utilized in this
manuscript is given below.
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Table 2.1. Efflux and molecular parameters for data set molecules (see text for further description).
Reported MIC ratiosa
MIC range
Avg
for WT
Log2(avg.
LogP
No.
Antibiotic
MIC
Ref Ref Ref Ref Ref
c
pump
MIC
ratio)
(AlogPs)
ratio
23b 24b 25b 27b 37b
(µg/ml)
1
Cefoxitin
4
4
4
4
2
0.22
2
Cefalothin
1
4
2-8
2.5
1.322
0.63
3
Cephaloridine
2
2
2-8
2
1
1.67
4
Ceftazidime
1
0.12
1
0
0.78
5
Cephalosporin C
1
16
1
0
-2.18
6
Cefotaxime
4
2
0.12
3
1.585
0.14
7
Cefepime
1
1
0.0075
1
0
-1.54
8
Cefpirome
1,2
0.015
1.5
0.585
1.57
9
Ceftriaxone
1
2
0.015-0.12
1.5
0.585
-0.01
10
Cefuroxime
16
8
1.56-2
12
3.585
-0.24
11
Cefamandole
4, 8
4
4
5.33
2.415
-0.05
12
Cefoperazone
2
0.03
2
1
-0.11
13
Cefmetazole
1
1
2
0.05
1.33
0.415
-0.38
14
Cefazolin
1
1
0.39-0.5
1
0
-0.4
15
Cefsulodin
1
1
16-64
1
0
0.6
16
Penicillin G
2
32
8-16
17
4.087
1.92
17
Penicillin N
1
8
1
0
-1.43
18
Carbenicillin
1, 4
4
1
1.56-8
2.5
1.322
1.13
19
Ampicillin
2
2
4
0.78-12.5
2.67
1.415
0.88
20
Amoxicillin
1
4
1
0
0.75
21
Oxacillin
512
256
1024
384
8.585
2.05
22
Sulbenicillin
4
1
8
2.5
1.322
0.37
23
Mezlocillin
32
1
36
5.170
0.21
24
Nafcillin
128 128
200
128
7
3.21
25
Cloxacillin
128 256 128
256-512
171
7.415
2.61
60

Mol.
Width
(Å)d
8.82
7.87
8.47
8.52
8.16
7.62
8.73
8.99
8.66
8.82
8.28
11.03
8.44
8.32
9.54
6.99
7.82
7.07
7.07
7.79
8.77
7.33
10.16
8.84
8.56

Table 2.1 continued…
26
Azlocillin
27
Piperacillin
28
Aztreonam
29
Mecillinam
30
Faropenem
31
Imipenem
32
Latamoxef
33
Chloramphenicol
34
Florfenicol
35
Methotrexate
36
Acriflavine
37
Proflavine
38
Tetracycline
39
Sulfacetamide
40
Novobiocin
41
Nalidixic acid
42
Ethidium bromide
43
Ciprofloxacin
44
Norfloxacin

4, 8
16
1
2
4
1
1

32

64

8
8
8
128
8
8
1
64
2
256
4
1

4

a

16
4
0.05
0.5
0.39
0.12
0.12
4-6.25
6.25
640
400
100
1.25
2000
32-100
3.125
800
0.01
0.004

6
16
1
2
4
1
1
6
8
8
128
8
8
1
53.3
2
256
4
1

2.585
4
0
1
2
0
0
2.585
3
3
7
3
3
0
5.736
1
8
2
0

0.2
0.67
0.06
1.41
0.24
-0.19
0.22
0.11
0.98
-0.91
2.56
2.10
-0.56
0.15
3.07
0.95
4.33
-0.57
-0.47

9.92
10.92
7.87
6.95
6.98
7.36
8.43
7.27
8.45
9.48
9.39
5.99
8.88
6.27
8.68
9.62
9.01
9.07
9.46

The MIC ratio is the ratio of minimum inhibitory concentration (MIC) in the presence of efflux pump to the MIC in the absence of the
pump. All reported MIC ratios are for the E. coli AcrAB-TolC pump, or the closely related S. typhimurium homolog.
b
All WT strains used include JC7623, SH5014, TG1, HS414 and ECM1194 while all pump knockout strains include JZM120,
SH7616, KAM3/pHSG398 or pHSG299, HS832 and ECM1694.
c
LogP was predicted by the ALogPs method [41-43].
d
The molecular width of each efflux substrate was calculated by performing a molecular dynamics simulation of 1 ns duration,
followed by aligning the farthest atoms along the Z axis and measuring the projection of all other atoms on the XY plane. Assuming
that the molecule spins rapidly, the largest such projection gives us a rough measure of its molecular width.
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Figure 2.1. Docking Efflux Substrates Into Different Regions of AcrB and TolC. All
32 -lactam and 12 non--lactam structures were docked into AcrB and several
overlapping regions of TolC. (A) The hydrophobic pocket of AcrB is shown for both
binding state (blue) and extrusion state (green) conformations. The numbered arrows
indicate the specific locations of AcrB in which the substrate molecules were docked: 1)
binding state, 2) intermonomer region, 3) the extrusion state. (B) Molecular surface of
the TolC channel shown colored according to cavity depth. The peaks are shown in
copper brown, while troughs are shown in blue. (C) Ribbon cartoon of a TolC monomer,
depicting its twisted shape. (D) The straightened cartoon avatar of one TolC monomer,
showing different zones where antibiotic structures were docked. All the zones
overlapped sufficiently to ensure a thorough investigation of molecular interactions
between the entire TolC lumen surface and each antibiotic.
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2.2.4 LogP calculations.
LogP was calculated by using an online server [44], which gave values of multiple
LogP prediction methods including ALogPs, ALogP, MLogP, XLogP2 and XLogP3 [4446] that are based on different principles and yet are known to predict LogP values quite
well. Our regressions, however, stipulated that only one set of LogP values could be
used in any resulting equation in order to avoid using multiple highly correlated
descriptors, which would have led to models with exaggerated statistical parameters.
The best correlation between predicted LogP and efflux was shown by ALogPs values.
For comparison and to evaluate the significance of differences between LogP calculated
for charged and uncharged forms of the molecules, LogP values were also calculated
for the β-lactams using HINT [39] (―calculate method‖, ―essential‖ hydrogens only).
2.2.5 Prediction of molecular width by molecular dynamics simulations.
Considering an efflux pump to be a tubular passage, one descriptor that we
expected to correlate with efflux was molecular width, i.e., it should have a negative
correlation with efflux, akin to a very large ball not being able to pass through a tubular
pipe.

For this purpose, we used molecular dynamics simulations to calculate the

effective width of the efflux substrates.

Figure 2.2 describes the physical concept

behind our calculations: we aligned each structure with the z-axis and calculated the
projections of its atoms on the x- and y-axes. The largest projection for each structure
was taken as its width. For completeness, we ran a 1 ns simulation for each molecule
using the Sybyl molecular dynamics module at 300K, recording snapshots every fs and
performed width calculations every 100 fs of simulation.
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The resulting average of

widths, calculated using 10,000 conformers for each ligand, was used as the molecular
width descriptor.

Figure 2.2. Calculation of Molecular Width. The figure shows ampicillin depicted in a
3D coordinate system, with the longest pair of atoms aligned with the Z axis. Projection
of an atom on the XY plane is shown and its length is depicted by R0. The largest X or Y
component of all such projections was taken as the radius of a cylinder C that can hold
the entire structure, which is an approximate measure of the width of the structure.

2.2.6 3D-QSAR methods.
The 3D-QSAR analyses were performed using the Comparative Molecular Fields
Analysis fields (CoMFA) module of Sybyl.

The β-lactam molecules were manually

aligned based on the common -lactam substructure and re-minimized to ensure no
structures with high internal strain energy were present during analysis. The set of 32
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-lactams was divided into two sets, a training set of 24 compounds and a test set of 8
compounds using a random number generator to avoid any bias in selecting training
and test sets. 3D-QSAR studies were performed for the charged and neutral forms
separately. All compounds thus aligned were placed in a grid (spacing 1 Å, margin 4
Å).

Both standard CoMFA fields (hydrogen bonding, electrostatic and steric

parameters) and HINT fields (hydropathic) were calculated at each grid point. Partial
Least Squares (PLS) and Sample-distance Partial Least Squares (SAMPLS) [47]
analyses were performed to correlate positions/properties of various chemical
substituents with efflux values.

Various descriptor field combinations were

comprehensively explored, creating several models to explore the predictability of each.
The selected best models, i.e., those showing highest cross-validated r2 (q2) at a
minimum (optimum) number of components, identified the descriptor field sets to be
used for further analysis.

2.2.7 The systems hydropathy method.
Using solely the 32 β-lactams, a statistical analysis of docking/scoring scores and
substrate physicochemical properties as descriptors was performed using PLS and
SAMPLS. During this investigation, only one predicted LogP value was used in any
given regression equation to avoid using multiple correlated descriptors. An exhaustive
search through the various HINT score sets calculated, as described above, for
substrate binding to the various pump zones, singly and in combination, was performed
to find the best possible descriptor combination.
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This model (vide infra), i.e., the

combination of descriptors that best quantified β-lactam efflux values, was then
extended to the non-β-lactam set. The complete set of 44 compounds was separated
into training sets of 33 compounds and test sets of 11 compounds. Cross-validation
was performed on these training sets and test sets to confirm internal stability of the
models.
2.3 RESULTS AND DISCUSSION
The intrinsic function of efflux pumps is to expel extraneously acquired molecules
that could harm the cell. These are promiscuous proteins that are largely responsible
for antibiotic resistance in Gram-negative bacteria. In contrast to normal receptors and
enzymes that bind or else catalyze reactions involving small molecules at a specific site,
the function of these proteins is to transport these small molecules – usually over fairly
large distances.

Perhaps due to this difference in function and the multiple steps

involved in what is clearly a dynamic rather than static process, their activity has been
resistant to computational chemistry/biology attempts at prediction. In fact, for a long
time, the only useful known trait of the AcrA-AcrB-TolC efflux pump was that it
transports hydrophobic molecules more easily [24].

However, recently available

crystallographic data for the AcrB and TolC components of this efflux pump has enabled
a more systematic and structural evaluation of the efflux mechanism [34].
We believed that this emerging structural information for pump molecules, combined
with modeling tools that effectively characterize hydrophobic interactions and related
effects, could illuminate the process of efflux. Our key technology is the HINT model
[39-41], which is an empirical modeling tool based on the free energy of solvent transfer
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between two phases, 1-octanol and water, representing hydrophobic and polar
biological environments, respectively. HINT has been used to evaluate ligand binding
[42,43], protein-protein associations [48-50] and other phenomena involving biological
molecules [51,52] and has been generally successful in quantitating the free energies of
these interactions.

In addition, qualitative representations of biological processes

involving molecular associations have been developed within the HINT paradigm; e.g.,
we recently developed molecular models validating previously proposed dual site
mechanisms for inhibition of paramyxovirus hemagluttanin-neuramindase [53,54].
In obtaining and curating a high quality and relevant data set for our analysis, we
restricted this study to 32 -lactam compounds (see scheme 2.1) and 12 non-β-lactams
from several families (see scheme 2.2), whose efflux data was available in published
reports [23-25,27,37]. Although similar data for them is available, the aminoglycoside
and macrolide classes of antibiotics are not included in the curated set; the former
because they are hydrophilic and therefore not effluxed as readily by the AcrAB pump the AcrD pump is apparently more responsible for their efflux than the AcrB pump
[55,56] and the latter because of their large size relative to that of the AcrB entrance.
However, we cannot discount the possibility that these antibiotics might enter TolC via a
different route [57], thus still involving parts of the AcrA-AcrB-TolC pump (and
concomitantly being affected by the pump knockout mutants). We recognize that a
much larger but proprietary set of data is very likely available within pharmaceutical
companies, but wanted the entire data set to be available from the primary literature for
this initial work. The experimental measure of efflux used in this study is Log2(MIC
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ratio), where the MIC (minimum inhibitory concentration) ratio is the MIC for a cell with
an intact AcrA-AcrB-TolC pump normalized by the MIC for that cell with the pump
knocked out.

Using this ratio in lieu of MIC itself has benefits as it more clearly

represents the change in effectiveness of an antibiotic. In contrast, MIC is a poorer
target metric as it is dependent on a number of factors such as concentration of cells
per unit volume of culture and is thus more laboratory and procedure-dependent.
2.3.1 3D-QSAR.
It seemed possible that binding in the AcrB pocket would affect the efflux of
substrates more than binding elsewhere in the pump because it has been shown that
this protein must undergo a conformational change in order to pass substrates into TolC
[34]. One way to test this is to perform 3D-QSAR analyses where the interactions
between substrates and a hypothetical but undefined receptor are simulated by the
molecular fields of the substrates. This approach was applied to the β-lactam data set
after conformationally aligning these molecules to simulate their putative binding modes
within a binding site presumed to be AcrB. If such an analysis provided predictive
results with respect to efflux, then we could at least partially address our goal of
predicting high or low efflux. We performed this 3D-QSAR study of the β-lactam data
set with molecules in both their charged and neutral forms using the Comparative
Molecular Field Analysis (CoMFA) method of Cramer [58]. The results seem promising
for neutral compounds, with a cross-validated r2 (q2) = 0.53 (4 components) on the
training set of 24 compounds and a (predictive) r2 = 0.80 for the test set of 8
compounds, as illustrated for a typical run in Figure 2.3. This model used the CoMFA
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Standard Steric field, H-bond Steric field and H-bond Electrostatics field (0.35), with
relative contributions of 27%, 38% and 35%, respectively.

Although their internal

statistical metrics were initially acceptable, CoMFA models for β-lactam substrates in
their charged state could not be validated.
However, 3D-QSAR experiments are dependent upon the alignment of a common
substructure, in this case the β-lactam.

Thus, this model formalism would not be

utilizable for the extended dataset including the non-β-lactams. Furthermore, these
experiments are based on the assumption that substrates bind to a single site in the
pump, whether in AcrB as we proposed or elsewhere, when in fact AcrB changes
conformation between its binding and extrusion states [34]. Thus, there must be a
dynamic change in its interactions with ligands as they are processed. In fact, the
binding pocket of AcrB is lined with a number of hydrophobic phenylalanine residues
[34], indicating a preference for hydrophobic or, at a minimum, less polar substrates –
suggesting that ligands would more favorably bind in their uncharged forms.
At the same time, we cannot ignore the possibility that the phenylalanine rings could
also be acting as receptors for -cation interactions.

The 3D-QSAR results above

support the assertion of ―neutral state‖ binding to AcrB and may be interpreted as
evidence of at least transient binding at this site being a rate-limiting initial step. In
contrast, the TolC lumen is exposed to the extracellular environment due to its position
on the bacterial outer membrane and this lumen is very likely solvated – suggesting that
ligands bound here would favor their charged form. The translocation of substrates
from AcrB to TolC must expose them to water, providing a mechanism for transforming
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them from their uncharged to charged forms. Substrates by necessity interact with
various parts of AcrB and TolC during their efflux extrusion and the process of efflux is
certainly affected by a multitude of different interactions and thus cannot be completely
addressed by simple methods such as 2D or 3D-QSAR that are based on molecules in
a single state, bound within a single well-behaved binding site/mode with the
concomitant assumption of a pharmacophore recognition-driven process.
While the 3D-QSAR model is unfortunately not extensible to other substrate families
because of the requirement that the molecules in the model have a common alignment,
the results for the β-lactam data set are an indicator of key principles behind the pump
mechanism.
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Figure 2.3 Training set and test set validations for 3D-QSAR models. Two runs
show variable predictions of efflux values of substrates. The (A) training set and (B)
test set for the first run are shown along with the (C) training set and (D) test set for the
second run. The cross-validated r2 (q2) is indicated for the training sets and the
predictive r2 is indicated for the test sets. While the first run shows a useful model, the
second signifies instability of the model.
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2.3.2 What factors might affect efflux?
The extrusion of ligands through an efflux pump such as AcrA-AcrB-TolC must
depend on a number of factors, including certain properties of the substrates
themselves as well as their interactions with the protein complex as measured by
docking/scoring calculations.
First, the size of the substrate molecules would seem to be one of their most critical
features.

Molecular widths were calculated by molecular dynamics simulations, as

described above in the Experimental Section. These values for each molecule are
listed in Table 2.1. In designing this parameter, we had presumed that there would be a
negative correlation, i.e., molecules with larger cross sections would be effluxed with
more difficulty. Also, the previous reports of a correlation between LogP and efflux [31]
mandated the use of this descriptor.

Although it would definitely be preferable to

incorporate experimental LogP values in our study, they are not uniformly available.
The LogP calculations were performed using several methods, but the best correlation
between predicted LogP and efflux was shown by ALogPs (Table 2.1). LogP alone (see
Figure 2.4) is clearly insufficient to describe efflux effectively. In addition, to account for
the dynamic nature of efflux, intermolecular interactions between efflux substrates and
various zones or compartments of the pump must be coordinated in order to transport
the substrates through the pump. Thus, the substrate molecules were docked into
various locations within AcrB and TolC.

These docked positions are direct

representations of interactions between substrate and the efflux pump subunits. Using
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the HINT model to score these interactions gives us an additional advantage of taking
desolvation energy and entropy into account at these loci [39].
2.3.3 Systems hydropathy.
Since efflux pumps conduct substrates from the periplasmic space to the extracellular
medium, this process is affected in multiple ways by interactions of the substrates with
the transporter protein, which can be simulated by docking the substrates in the AcrAAcrB-TolC pump. However, as there are not specific and well-defined docking region(s)
within the pump, the substrates were docked into multiple zones or compartments, in
both their charged and uncharged forms, as illustrated in Figure 2.1. Important sites
were thus initially surveyed with -lactams within the binding and extrusion states of
AcrB. Since the TolC lumen is open to the extracellular space, ligands present here
should be solvated and exist mostly in their charged forms. Again, the -lactams were
used to survey the potential sites within TolC.

Compartmentalization of individual

events (albeit of a different variety and on a different size scale) is also seen in the
‗systems biology‘ approach; each compartmentalized effect is recorded individually, but
the effects are viewed on a holistic level in order to study trends that cannot be
observed by the reductionist approach. Similarly, we interpret the larger efflux effect as
partially being a result of compartmentalized hydropathic interactions between substrate
and pump, leading us to call our method ‗systems hydropathy‘.
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Efflux = 1.2936*LogP + 1.457
r² = 0.48

Experimental Efflux

9

Efflux = 0.2501*LogP2
+ 0.7903*LogP + 1.2549
r² = 0.54
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Figure 2.4 Correlation Between ALogPs Predicted LogP Values and Efflux. The
plot of predicted LogP values versus efflux shows an r2 value of 0.48, illustrating the fact
that LogP alone does not allow prediction of antibiotic efflux. Also shown is the
quadratic fit of Efflux with respect to LogP (Efflux = a + b*LogP + c*Logp 2), which shows
an r2 value of 0.55.
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A partial least squares (PLS) analysis was conducted to explore the interplay
between the substrate molecular properties and the interactions between the
charged/uncharged -lactam antibiotics and the AcrB and TolC proteins.

Multiple

equations of correlation were obtained through exhaustive exploration of the descriptor
space. Only those descriptors that showed both interpretable trends and significant
contributions to a model fitting the set of 32 β-lactam molecules were retained. With the
important descriptors and binding sites thus identified, the 12 non-β-lactam substrates
were docked and scored at those sites. The best combination of descriptors yielded the
final multilinear model:
Efflux = - 1.31 – (1.7x10-4)*HINTnB – (5.3x10-4)*HINTcE + (6.9x10-4)*HINTAcrB(hole) –
(1.0x10-3)*HINTZ3 + 1.10*LogP + 0.43*MolWidth

(eq. 1)

Here, HINTnB is the HINT score of the neutral substrate docked to the AcrB binding
state. Similarly, HINTcE is the HINT score of the charged substrate in the AcrB extrusion
state. HINTAcrB(hole) and HINTZ3 represent the HINT scores of the charged substrate at
the intermonomeric space of AcrB and zone 3 of TolC, respectively. LogP values are
as predicted by the ALogPs algorithm, chosen as described above due to their better
correlation with efflux and MolWidth is the molecular width. A table with all descriptor
values for each compound is given in appendix B.
Cross-validation with leave-one-out on the data set yielded a q2 of 0.56 and an r2 of 0.66
with 2 components for equation 1.

Figure 2.5A displays the predictive model of

equation 1 and table 2.2 sets out the predicted efflux and deviations calculated. To
further evaluate the predictive ability of the model, the data set of 44 compounds was
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randomly divided into training sets of 33 compounds and test sets of 11 compounds.
New models were built with leave-one- out cross-validation over the training sets and
used to predict the efflux of their corresponding test sets. The predicted test set efflux
for a typical run of this nature is illustrated in Figure 2.6.
It is probably more important to classify substrates as being susceptible or not to
efflux than to predict their numerical MIC ratio. Thus, using a definition of ―high‖ efflux
as ≥ 4, the equation 1 model was able to identify low/high efflux molecules with a
93.18% (41/44) success rate. Other results, i.e., with different high/low cutoffs, are
summarized in Table 2.3. Note that even the predictions in error in terms of this binary
classification scheme are often fairly close to the experimental efflux (Table 2.2). In
summary, this method allows reliable predictions for whether a given antibiotic is a good
substrate for efflux by the AcrA-AcrB-TolC pump.
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Table 2.2. Efflux predictions for data set molecules.
Average MIC ratio prediction (Equation 1) MIC ratio prediction (Equation 2)
a
MIC ratio
MIC ratio
Error
MIC ratio
Error
1
4
3.34
-0.66
2.78
-1.22
2
2.5
4.00
1.50
2.34
-0.16
3
2
10.13
8.13
6.48
4.48
4
1
3.31
2.31
2.73
1.73
5
1
0.42
-0.58
1.22
0.22
6
3
2.35
-0.65
1.89
-1.11
7
1
0.69
-0.31
2.18
1.18
8
1.5
6.21
4.71
6.39
4.89
9
1.5
2.37
0.87
2.57
1.07
10
12
3.64
-8.37
3.11
-8.89
11
5.33
1.19
-4.15
1.45
-3.88
12
2
3.46
1.46
4.97
2.97
13
1.33
1.50
0.16
1.44
0.11
14
1
1.61
0.61
1.28
0.28
15
1
2.32
1.32
2.43
1.43
16
17
13.70
-3.30
9.06
-7.93
17
1
1.21
0.21
1.39
0.39
18
2.5
8.77
6.27
5.16
2.65
19
2.67
1.72
-0.94
1.55
-1.12
20
1
2.88
1.88
1.48
0.48
21
384
59.84
-324.17
83.29
-300.72
22
2.5
2.09
-0.41
1.62
-0.88
23
36
4.88
-31.12
4.04
-31.97
24
128
64.80
-63.20
101.62
-26.38
25
171
133.07
-37.60
437.76
267.10
26
6
8.33
2.33
5.30
-0.70
27
16
14.55
-1.45
8.80
-7.20
28
1
1.80
0.80
1.33
0.33
29
2
12.73
10.73
10.01
8.01
30
4
4.49
0.49
4.25
0.25
31
1
0.41
-0.59
0.79
-0.21
32
1
3.49
2.49
2.46
1.46
33
6
0.76
-5.24
1.67
-4.33
34
8
11.73
3.73
5.61
-2.39
35
8
2.89
-5.11
3.26
-4.74
36
128
34.78
-93.22
30.80
-97.20
37
8
9.09
1.09
6.29
-1.71
38
8
4.35
-3.65
3.38
-4.62
39
1
1.78
0.78
1.28
0.28
40
53.3
43.32
-9.98
47.34
-5.96
41
2
9.12
7.12
6.78
4.78
42
256
100.92
-155.08
307.41
51.41
43
4
2.56
-1.44
3.33
-0.67
44
1
3.18
2.18
3.53
2.53
a
The MIC ratio is the ratio of minimum inhibitory concentration (MIC) in the presence of efflux pump to the
MIC in the absence of the pump.
Antibiotic
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Table 2.3 Classification accuracy of efflux predictive model.
Definition of “High”
Efflux

% Correct
Predictions (Eqn. 1)

≥4
≥3
≥2
≥1

93.18 (41/44)
79.55 (35/44)
72.73 (32/44)
77.27 (34/44)

78

% Correct
Predictions (Eqn.
2)
93.18 (41/44)
84.09 (37/44)
70.45 (31/44)
72.73 (32/44)
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Figure 2.5 Correlation Plots for Predicted vs. Experimental Efflux as Obtained
with the Systems Hydropathy Approach. Predicted versus experimental efflux values
plotted for all 44 ligands based on (A) equation 1 and (B) equation 2.
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Figure 2.6 Systems Hydropathy Validation. Predicted Versus Experimental Efflux For
Training and Test Set Substrates. (A) Correlation between the predicted and
experimental efflux values for training set of 33 compounds using leave-one-out crossvalidated model built with descriptors of eq. 1. (B) Correlation between the predicted
and experimental efflux values for independent test set of 11 compounds using equation
of (A). (C) Correlation between the predicted and experimental efflux values for training
set of 33 compounds using leave-one-out cross-validated model built with descriptors of
eq. 2 (D) Correlation between the predicted and experimental efflux values for
independent test set of 11 compounds using equation of (C).
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2.3.4 Model and descriptor interpretation.
A key requirement for a universally useful predictive model is that the
physicochemical implications of the model‘s descriptors are interpretable and intuitive.
The descriptors must yield not only statistical information but also chemical information
that can be applied to fruitful drug design. However, when considered together, as in a
regression equation, the model should have more value than the sum of its parts, i.e.,
the individual descriptors. Table 2.4 shows the fractional contribution of each descriptor
for the model.

All descriptors were found to have a significant contribution in the

prediction of efflux values, with LogP having the largest, a nearly 41% contribution, to
the model.

In this section the descriptors and their qualitative and quantitative

contributions to the overall model are described.
First, we should describe the roles that effects represented by LogP may play in the
biological process. LogP represents more than solubility and related phenomena. This
is especially true in the study of MIC ratios because the phenomenon is composed of
two independent events: influx of the antibiotic through the outer membrane, followed by
extrusion of the same by an efflux pump. LogP plays an important role during
permeation of the antibiotic through the outer membrane, as has repeatedly been
described by Lipinski‘s rules [59,60]. Also, since the AcrB binding pocket, which
captures antibiotics and other substrates to commence efflux, is hydrophobic, it is not
hard to imagine the importance of this descriptor in the process of efflux. Especially
when the range of compounds is large, LogP can often be better represented in a
quadratic form in QSAR equations, i.e., a + b*LogP + c*LogP 2 [61,62]. This form allows
81

for the likely scenario that both too high and too low LogP are detrimental to the
biological effect being modeled and that there is an optimum range of LogP. In the case
of efflux (i.e., log2[MIC ratio]), even though the linear relationship between LogP and
efflux, i.e., Efflux = a + b*LogP, is fairly good (r2 = 0.48), there is a modest improvement
with the quadratic to r2 = 0.55 (see Figure 2.4). Both forms of the regression support
our expectation that more hydrophobic moieties are more easily effluxed by the pump.
The quadratic probably provides a better fit due to the peculiarities of the data – in that
there is no negative efflux – presumably, compounds with very negative LogP would
have an efflux of zero. Overall, both support the model that ligands are initially captured
by AcrB and then transported into the solvated TolC lumen and that those ligands with
highly negative LogP values will be unable to enter the hydrophobic AcrB binding
pocket. We hypothesize that ligands with highly positive LogP values (more positive
than in this data set) would be able to easily enter AcrB but then resist deposition into
the polar environment of the TolC lumen and thus ―clog‖ the pump.
Table 2.4. Fractional contribution of descriptors to models.
Percent
Percent
Descriptor
Contribution
Contribution
(Equation 1)
(Equation 2)
2
LogP
20.5
LogP
40.9
22.0
2
HINTZ3
12.7
HINTZ3
18.2
10.9
HINTAcrBhole 2
4.2
HINTAcrBhole
11.9
3.5
HINTnB
2.6
0.7
HINTcE
13.0
13.3
MOLWIDTH
13.5
10.6
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It is likely that HINTnB appears in the equation because these substrates should bind
to the AcrB protein‘s binding state in their neutral form. It has previously been proposed
that efflux pumps capture antibiotics from the periplasmic region [34]. Since this region
is lined on either side by lipid bilayers, this environment is less polar than that of the
cytosolic medium. This would, thus, partially shift the acid-base equilibria for ligands in
the periplasmic space towards their non-ionic (more hydrophobic) forms. As there are
several phenylalanine residues in the AcrB binding pocket, it is thus quite hydrophobic
and this, the entrance to the pump, would preferentially bind less polar ligands, or those
that are in a non-ionic form at the time of capture. This would suggest that a number of
substrate molecules linger near the entrance and only pass within when their
equilibrium-mediated ionization state matches the requirements of the AcrB binding
pocket.

Confusingly, this term has a negative correlation coefficient that suggests

strong binding here disfavors efflux. This, in a sense, would appear to be true, as very
strong binding to this site should cause the substrate to be ―stuck‖ and not effluxed. Of
course, negligible binding to this site should also be a negative factor, but presumably,
intermediate binding should favor efflux. Much as above, this should be a classic case
for using quadratic descriptors (e.g., a + b*HINTnB + c*HINTnB2) in constructing
regression models, but as the contribution of HINTnB in the model of equation 1 is quite
small (see Table 2.3), we should not expect a strong correlation in models using only
this independent variable in any case. Thus, as observed in figure 2.8A, the attempt to
fit efflux with only the HINTnB quadratic descriptor yielded a poor regression (r2 = 0.030)
compared to the linear fit of efflux with HINT nB (r2 = 0.028). Moreover, it must be noted
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that while a high HINTnB score would favor the capture of antibiotics by AcrB, this
phenomenon can also be facilitated, at least in part, by simply ―partitioning‖ molecules
into the AcrB binding pocket, a phenomenon that is likely encoded in the dominant LogP
descriptor.
After AcrB captures a ligand, it undergoes a conformational change as observed
in its crystal structure (PDB code 2drd) [34], where both ligand-bound and unbound
states were observed in the same multimeric structure. The conformational change
opens up the binding pocket towards the TolC lumen. The ligand would now likely be
bathed in water entering the AcrB binding pocket from the extracellular environment
through TolC.

This (suddenly) now polar environment would shift the acid-base

equilibria towards favoring charged forms of the ligands.

Thus, we propose the

significance of the HINTcE descriptor that represents binding in the AcrB extrusion state
in our models. Similar to above for HINT nB, the HINTcE descriptor also has a negative
correlation coefficient in the models and thus also represents a complex effect. In this
case the effect was not better modeled in this data set by using a quadratic
representation: a + b*HINTcE + c*HINTcE2 (r2 = 0.148) cf. linear (r2 = 0.148, figure 2.8B),
so the simple explanation is that tight binding here is detrimental to efflux. Substrate
ligands washed out of the hydrophobic pocket of AcrB in their charged forms would
have a higher affinity towards the intermonomeric region that has a higher density of
charged residue sidechains. The positive coefficient of HINTAcrBhole is indicative of the
―pull‖ exerted on ligands by this region, enabling it to exit the extrusion state of AcrB
towards the TolC channel. For this descriptor, the quadratic representation (r 2 = 0.044)
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gives a slightly better correlation than that of the simple linear model (r2 = 0.003), but
both are poor, in concert with the small contribution of this descriptor to the model. This
does suggest the possibility that both weak and tight binding can inhibit efflux. Linear
and quadratic relationships between efflux and HINT AcrBhole are demonstrated in figure
2.8C.
On traversing through the TolC lumen, the substrate would successively interact with
multiple positions on the protein. In accordance with our theory that stronger
interactions slow down extrusion of ligands, the term HINT Z3 correlates negatively with
efflux in our regression equations. This is easily explained by looking at the inner
surface map of TolC (figure 2.9A). Zone 3, which happens to be a deep pocket, is found
in the center of the TolC lumen surface (figure 2.9B). Although a transient attraction
between the substrate and the residues at this site may favor the substrate‘s passage,
strong interaction with this deep pocket would slow or halt the passage of ligands
through the TolC lumen, thereby reducing the extent of efflux by the pump. This effect
is somewhat better modeled with a quadratic descriptor (r2 = 0.219) rather than linear (r2
= 0.192), which are delineated in figure 2.8D.
Molecular width (MolWidth) appears in equation 1 and possesses an unexpected
positive correlation coefficient; i.e., larger substrates are more favorably extruded by the
pump. We are proposing that this effect arises from ‗induced fit‘ of larger substrates on
AcrB, thus forcing AcrB to transform from the unbound and flaccid access state to the
much larger binding state. Also, the substrate bulk could force a change in tertiary
structure that causes AcrB to assume the extrusion state. There is experimental
85

evidence to support this hypothesis: the crystal structure (PDB ID 2drd) of AcrB clearly
shows that the binding pocket is shrunken in the access state, while in the binding state
it is wide open with an entrenched ligand [34]. After releasing the ligand, the pocket
returns to its shrunken conformation in the extrusion state.

It has previously been

suggested that the proton pump mechanism provides energy for conformational change
[63]. We propose that binding of larger ligands might supplement (or trigger?) this effect
by providing steric ―encouragement.‖ However, in agreement with our initial assumption,
we still believe that transitioning beyond a certain size should also be detrimental for
efflux. In other words, this descriptor also should be better represented in quadratic
form. However, as observed in figure 2.8E, the quadratic relationship (r 2 = 0.055)
yielded only a small improvement when compared to the linear model (r 2 = 0.054). This
is possibly due to the small range of molecular width possessed by the compounds in
our dataset.
To consolidate the above information, we suggest equation 2, in which LogP,
HINTAcrBhole and HINTZ3 are modeled in their quadratic forms:
Efflux = - 2.09 – (4.9x10-5)*HINTnB – (6.1x10-4)*HINTcE + (2.3x10-4)*HINTAcrBhole –
(6.8x10-4)*HINTZ3

+

0.66*LogP

+

0.44*MolWidth

+

0.22*LogP2

7

)*HINTAcrB(hole)2 + (1.04x10-7)*HINTZ32

+

(2.1x10(eq. 2)

This model has q2 = 0.63 and r2 = 0.73 with 2 components. Its results are presented in
Figures 2.5B, 2.6C and 2.6D and Tables 2.2, 2.3 and 2.4.

While a noteworthy

improvement in statistical parameters was observed, no apparent change in the model‘s
ability to correctly predict high/low efflux (Table 2.3).
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However, it must be

acknowledged that this model is at higher risk of being statistically invalid because of
the addition of three more fitted parameters for the coefficients of the squared terms.

Figure 2.7 Surface Maps for TolC. (A) An electrostatic surface map of TolC shows the
surface of the TolC lumen (enclosed by the red circle) (B) Zone 3 of the TolC efflux
pump is a deep cavity on the wall of the lumen, with blue depicting peaks while bluegreen depicts troughs.
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Figure 2.8 Relationship between Efflux and Individual Descriptors. Linear and quadratic
models for the relationship between efflux and each descriptor used in this study are
demonstrated. Efflux as a function of (A) HINTnB and (B) HINTc# are demonstrated.
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Figure 2.8 continued. Efflux as a function of (E) molecular width.
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Figure 2.9 summarizes our proposed mechanism for the AcrA-AcrB-TolC efflux
process. The dielectric environment within the periplasmic region is unknown, but it is
likely that there is less water present between the two lipid bilayers than in either the
extracellular or cytoplasmic regions (see Figure 2.9A that indicates the color scales
used in the remaining panels of Figure 2.9). Furthermore, the periplasmic space is
occupied by peptidoglycan chains and a gel containing a wide variety of enzymes,
which should tend to reduce the polarity. Efflux substrates in the periplasm would exist
in a reversible equilibrium between their charged and uncharged forms that slightly
favors the uncharged forms (Figure 2.9B, inset) in this (slightly) more hydrophobic
region. The uncharged forms will be more likely captured by the AcrB hydrophobic
pocket (Figure 2.9B), upon which AcrB will assume the extrusion state (Figure 2.9C)
partly due to the bulk of the substrate, as indicated by the positive correlation between
efflux and molecular width. It should be pointed out that if a substrate molecule binds
too tightly to the binding state form of AcrB, or if it cannot sterically trigger the extrusion
state of AcrB, that substrate would appear to be immune from extrusion and may block
the pump‘s function. The absence of favorable substrate binding at this state would
also preclude efflux. Once the extrusion state is formed, the AcrB entrance is closed
and thus isolated from the periplasmic space but now open towards TolC, exposing the
substrate to water present in the TolC lumen (Figure 2.9C).

Similarly, the ligand‘s

ionization equilibrium is concomitantly shifting towards the charged form (Figure 2.9D,
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Figure 2.9 Proposed Efflux
Mechanism. (A) Color ramps
for hydrophobic-polar (green
to purple) and acid-base
(blue to red) spectra. (B)
Antibiotics present in the
periplasmic region exist in
equilibrium between their
charged
and
uncharged
states (inset). The uncharged
forms predominate due to the
local environment and are
captured
by
the
AcrB
hydrophobic pocket. (C) AcrB
assumes extrusion state
partly due to the bulk of the
substrate and is isolated from
the periplasmic space. The
cavity is now open towards
TolC, exposing the substrate
to water present in the TolC
lumen. (D) The ionization
equilibrium shifts towards the
charged form (inset) and the
substrate is released into the
intermonomeric space of
AcrB. (E) The charged efflux
substrate is now able to
diffuse through the water
present in the TolC lumen.
The electric field present
inside the TolC lumen causes
orientation of the substrate
such that negatively and
positively charged groups
point towards opposite ends
of the protein. (F) The efflux
substrate is released into the
extracellular space.
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inset), leading to release of the substrate into the intermonomeric space of AcrB (Figure
2.9D). Again, if the substrate ligand binds too weakly or too tightly to the AcrB extrusion
state, it may not be effluxed and, in fact, may in the latter case block the pump.
However, both these ―clogging‖ events involve equilibria that may reverse to unclog the
pump. The charged efflux substrate can now diffuse through water present in the TolC
lumen (Figure 2.9E). Ultimately the substrate will be extruded into the comparatively
polar extracellular medium (Figure 2.9F).

2.4 CONCLUSIONS
Despite the engineering of Nature to facilitate the extrusion of undesired molecules
within a cell, there are likely to be multiple reasons why a particular substrate is
resistant to efflux. In addition to the obvious descriptors of hydrophobicity (LogP) and
size (although the correlation with molecular width we observed was initially
counterintuitive), the ligand‘s ability to bind and release from various pockets within the
pump machinery is at least as critical as the aforementioned descriptors that are not
cognizant of its interactions with the pump. However, despite the relatively successful
predictions of efflux by these models, there are a number of considerations inherent in
the approach that should be discussed. Primary is the dataset itself. Unfortunately, the
available data is both relatively small in quantity and skewed towards the lower efflux
range, which corresponds to the range of molecules of more clinical interest.

Our

development of regression model equations with six descriptors on 44 substrates using
PLS is not ideal, while our expanded model with three of these variables represented in
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quadratic form is potentially bordering on overfitting. Although we have some comfort
from the fact that these models were subjected to cross-validation, which yielded good
statistical parameters, Wold and Dunn [64] state that, even when using PLS, regression
studies are only valid when the number of independent variables is far less than the
number of dependent target values. Clearly, we would like to have a larger data set, but
restricted this analysis to the -lactam class of antibiotics and some non-β-lactam
antibiotics because of their loose chemical similarities that, in turn, suggest efflux
extrusion by the same pump and mechanism. Data from a wider class of antibiotics are
potentially available, but their use may be premature in testing a new computational
method.
In conclusion, we have proposed the systems hydropathy approach, which has been
used in this work to predict efflux values of the AcrA-AcrB-TolC efflux pump. The
analogy to systems biology stems from our combining the various compartmentalized
functions of the pump‘s protein components into a holistic model that has more value
than a reductionist analysis of the pump. Nevertheless, the model suggested some
interesting mechanistic details about the efflux process that seem intuitively true. On
further development, this approach could be expanded to more non--lactam antibiotics,
other efflux systems affecting antibiotic efflux and potentially mammalian efflux systems
that have been shown to extrude, among other molecules, anticancer chemotherapeutic
agents. The key puzzle piece is obtaining structural data for the protein components of
additional pump molecules.
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CHAPTER 3
TARGETING PARAINFLUENZA VIRUS TYPE 3 BY VIRTUAL
SCREENING; THE NEED FOR NEW TOOLS
3.1 AN INTRODUCTION TO HUMAN PARAINFLUENZA VIRUSES
Among the four human serotypes of parainfluenza viruses, Human Parainfluenza
Viruses (HPIV) 1, 2, 3 and 4, HPIV3 is mostly implicated in bronchial pneumonia [1]. All
the serotypes are known to be causative agents of acute lower respiratory diseases in
infants and children [1,2]. HPIV3, which belongs to the Paramyxoviridae family of
negative-stranded RNA viruses, is responsible for approximately 11% of the
hospitalizations of pediatric patients in the United States [2]. Cell mediated immunity is
important for preventing parainfluenza related diseases. For example, HPIV3 infection
in T-cell deficient children can cause fatal giant-cell pneumonia and HPIV pneumonia
shows 30% mortality in bone-marrow transplant patients [2].
Unlike other viral diseases, HPIV primary infections are known to not confer
permanent immunity [1]. For example, 30% of children with relatively high neutralizing
antibody counts were reinfected with the virus [2]. In fact in the 1960s, clinical trials of
the inactivated HPIV 1, 2 and 3 vaccines showed variable amounts of antibody
responses in seropositive and seronegative individuals, but failed to produce immunity
[1]. This inability of the human immune system to provide protection against these
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versatile viruses is a worrying factor, especially due to fears raised by a recent flurry of
related fatal avian and porcine influenza disease occurrences around the world.
The plausible impact of these viruses on healthcare (especially pediatric
healthcare) clearly delineates the importance of drug discovery efforts against the
human parainfluenza virus. Such an effort has been undertaken, the procedures and
results of which are described herein.
3.2 HEMAGGLUTININ-NEURAMINIDASE IN HPIV3 REPLICATION
The life cycle of HPIV3 starts with the recognition of sialic acid containing
receptors on the host cell by hemagglutinin-neuraminidase (HN), which then triggers
another membrane protein (F) [3]. The F protein is responsible for fusion of the viral
membrane with the host cell membrane [2]. Although sialic acid alone is sufficient to
trigger HN mediated F protein activity, it must be noted that not all sialic acid-containing
receptors are recognized equally effectively [4]. Moreover, the neuraminidase function
of HN is responsible for the release of new virions from the host cell [5] and thus is
responsible for persistent infectivity of the virus.
It has been shown that mutations on HN cause modulation of immune responses
toward this pathogen [2]. However, it is amply clear that unlike the Influenza A virus,
parainfluenza viruses do not evolve by mutation of this membrane glycoprotein [1]. In
fact, these viruses show a high sequence homology of 75% between even the human
and bovine variants. The hemagglutinin and neuraminidase epitopes of HN are
conserved across both these strains of the virus [1], which suggests the importance of
101

this protein in its life cycle. It is thus logical to devise strategies in order to inhibit this
protein.
3.3 INHIBITION OF HEMAGGLUTININ-NEURAMINIDASE STOPS VIRAL ACTIVITY
In order to understand the inhibition of HN and its mechanism, one must first
understand the biology behind the assays used to study this phenomenon. Following is
a description of assays described in literature, which are used to distinguish
hemagglutination and neuraminidase functions of HN.
3.3.1 Neuraminidase Assays
Potier and coworkers introduced a simple fluorometric assay for the quantitative
assessment of neuraminidase activity [6]. The basic principle of this assay is to
spectroscopically measure the release of 4-methylumbelliferone from the sodium salt of
2‘-(4-methylumbelliferyl)--D-N-neuraminic acid, when the substrate is exposed to a
neuraminidase enzyme (figure 3.1).
O
OH HN
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HO

Neuraminidase

O

O
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O
OH
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Figure 3.1 Principle of the Fusion Assay. Release of 4-methylumbelliferone as a result of
hydrolysis of 2‘-(4-methylumbelliferyl)-a-D-N-neuraminic acid by neuraminidase is measured by
fluorescence spectroscopy
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A similar assay was also developed by Warner and O‘Brien in the same year [7].
This method is accurate, with up to a 3% variation [6] observed in the original literature
by these authors.
This assay is used to assess the ability of the virus to cleave neuraminic acid
from receptors of host cells, leading to the destruction of these proteins and enabling
movement of new virions towards uninfected cells. Those viruses which lack
neuraminidase activity (or else whose neuraminidase activity is reduced due to the
presence of neutralizing agents such as antibodies and small molecule inhibitors) are
unable to travel towards new plausible host cells in order to spread infection. Therefore,
the most common use of this assay is to ascertain the persistent infective capabilities of
the virus.
3.3.2 Fusion Assay
Horvath et al. have shown that the F protein can mediate membrane fusion of
cells under the influence of HN [8]. However, in spite of the fact that both proteins are
expressed by cells persistently infected with HPIV3, they do not fuse with each other,
but readily fuse with non-infected cells [9]. This is because of the neuraminidase activity
of HN, which cleaves neuraminic acid from receptors, thereby inhibiting cell fusion
mediated by the protein. Further support for this theory comes from the fact that
neuraminidase treated uninfected cells do not fuse with persistently infected cells [9].
This phenomenon has been utilized in the development of an effective and
accurate assay in order to study the recognition of sialic acid (N-acetylneuraminic acid)
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containing receptors by HN [10]. Cells containing the LacZ gene (genetic code for
production of -galactosidase) under the control of HIV LTR (HeLa-LTR-gal cells) are
infected with HPIV3 in order to cause a persistent infection, but as explained above,
these infected cells do not fuse with one another. These persistently infected cells are
then exposed to cells engineered to express the HIV Tat protein (HeLa-Tat cells). Only
when these cells fuse does the Tat protein interact with the HIV LTR, thereby promoting
the production of -galactosidase by expression of the LacZ gene. The expression
levels of this enzyme can be measured readily, thereby revealing the extent of cell
fusion as an indirect measure of HN-receptor interactions.
3.3.3 Plaque Reductions Assay
When Bloom, Jimenez and Marcus first introduced the plaque assay [11], it was
aimed at studying the effect of various antigens on antigen-sensitive cells. Observations
clearly suggested that on antigen activation, such cells became more capable of
supporting viral replication. A monolayer of such cells was grown in a petri dish and
then exposed to live viral cultures. Any free virus was washed away post inoculation
and the infected cell culture was incubated. Infectious centers were observed as
plaques, which were directly related to the degree of activation of the antigen-sensitive
cells. A similar technique was also reported in later years [12].
Across time, this technique has been converted to a purely virology technique,
where the degree of plaque formation suggests the ability of the virus to replicate [10].
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The number of plaques being formed is directly proportional to the degree to which the
virus can replicate.

3.3.4 Hemadsorption Assay
When persistently infected cell lines are exposed to erythrocytes, whose cell
membrane contains sialic acid containing receptors, they are adsorbed onto the surface
of the infected monolayer [10]. An interesting fact is that the persistently infected cells
fail to fuse with erythrocytes, perhaps because of a difference in membrane composition
or cytoskeletal stiffness of the latter [13]. After incubation for a short time, washing
removes any erythrocytes which are not adsorbed. Such adsorbed cells can then be
visualized by phase contrast microscopy. The degree of adsorption is a direct
representation of the HN expression levels of the infected cells and hence is a measure
of hemagglutinin activity.
3.3.5 Neuraminic Acid Interaction with HN Mediates Membrane Fusion
It has been shown that cell fusion is mediated by the interaction between HN and
sialic acid containing cell receptors [13]. When uninfected cells were treated with
neuraminidase to destroy sialic acid containing receptors on their surface, membrane
fusion was not observed in a fusion assay. Similarly, cells which do not produce sialic
acid containing receptors did not show fusion with persistently infected cells in the
fusion assay. Moreover, it has also been demonstrated that HN is specific in its
selection of sialic acid containing receptors [4].
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3.3.6 DANA and GANA inhibit Hemagglutinin Function of HN
2,3-dehydro-2-deoxy-n-acetyl neuraminic acid (DANA) is known to inhibit viral
neuraminidase activity and its mode of action was investigated [10]. It was found that
DANA blocked fusion as well as gal production at 10 mM concentrations. The abolition
of hemadsorption in the presence of DANA suggests that it blocks HN-receptor
interactions (hemagglutinin function). DANA could inhibit 90% of plaque formation at
25mM concentrations.
Similar assays with 4-guanidino-DANA (GANA, a.k.a. Zanamivir) revealed
mechanistic details of this compound as well [14]. It blocked hemadsorption in C28a, a
variant of the HPIV3 virus that lacks neuraminidase activity, attesting to its HN-receptor
interaction blocking abilities. The plaque forming capabilities of both WT and C28a
viruses were blocked by DANA, demonstrating its ability to block fusogenic activity of
HN. The lack of neuraminidase function of C28a was corrected by adding exogenous
neuraminidase, which cleaves the host cell sialic acid-containing receptors. Thus, newly
formed virions are able to avoid attachment to the host cell and were released into the
environment. GANA also allowed release of new virions into the environment, palpably
by blocking HN mediated recognition of host cell receptors. In contrast, when cell lines
were exposed to WT HPIV3, virion release could not be blocked by addition of GANA.
This proves GANA inhibits HN by preventing binding to host cell receptors.
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3.4 VIRTUAL SCREENING FOR HN INHIBITORS
The above studies clearly showed the utility of sialic acid derivatives in inhibiting
HN activity and also HPIV3 by consequence. Therefore, inhibition of HN is a plausible
mode for antiviral activity. We therefore embarked on a search for inhibitors of HN.
Following is a description of the methods adopted for the search, along with a
discussion about problems encountered in the process.
3.4.1 Pharmacophore Identification
The crystal structures of HN in its unliganded form, bound to sialic acid, DANA
and GANA were published by Lawrence et al. in 2004 (PDB ID: 1v3b, 1v3c, 1v3d and
1v3e respectively) [15]. The protein shows a six-blade -propeller shape and was
crystallized in a dimeric form.
The unliganded binding pocket of HPIV3 HN is similar to that of influenza virus
neuraminidase, which is published elsewhere [16]. Figure 3.2 shows the interactions
between HN and its ligands. In spite of differences between sidechain positions of all
three HN-ligand complexes, the core sidechain positions of HN itself remain similar:
Three arginine residues (R192, R424, R502) project into one side of the cavity, while
the floor of the same side contains a tyrosine sidechain (Y530) hydrogen bonded to
E409. The sidechain position for Y530 varies across different forms of HN crystals
obtained, perhaps an effect caused by the variety of crystallization conditions used.
However, it is interesting that in one of the two observed sidechain positions of Y530, it
is ―slotted in‖ so as to form interactions with two highly conserved residues –
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hydrophobic pi-pi interactions with Y478 and hydrogen bonds with the P194 backbone.
In the same conformation, Y530 also forms a hydrogen bond with a water molecule.
R424 is also hydrogen bonded to E409. Another face of this cavity is partially
hydrophobic due to the presence of Y319. All in all R192, R424, R502, Y530, E409,
E549 and D216 form the active site residues.
When crystals of HN were soaked in 5-acetylneuraminic acid (sialic acid), the
crystal structure thus obtained (figure 3.2A) reveals that the carboxylate group on the
ligand interacts favorably with the three arginine cluster (R192, R424 and R502),
although only two of these (R192 and R502) are hydrogen bonded with it. The hydroxyl
group of Y530 and the glycosidic oxygen of sialic acid are less than 2.3 Å apart, while
the latter is only 3.5 Å away from the carboxylate group of E409. This suggests
hydrogen bond formation between these residues and the sialic acid glycosidic hydroxyl
group. The C7 and C9 hydroxyl groups of sialic acid are hydrogen bonded to E276,
while the N-acetyl group forms a hydrophobic interaction with Y319. The largest
structural perturbation caused by binding of sialic acid to HN observed in these crystal
structures is the movement of Y530 into the binding site cavity, which was observed in
the ―tucked in‖ conformation within the unliganded form in 30% of the crystals formed. A
water molecule also exists near the triarginyl cluster and the ligand carboxylate group.
The triarginyl cluster remains almost in the same position in the structure of HN
bound to GANA, except for a short movement of the guanidino group of R192 closer
towards the substrate carboxylate group (figure 3.2B). This suggests that an additional
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hydrogen bond might be formed between the protein and ligand due to the change in
position of the carboxylate caused by introduction of unsaturation in the pyranose ring.

109

The water molecule observed in the HN-sialic acid complex was not observed in
this complex, which perhaps contributes towards increased ligand affinity. The hydrogen
bonds formed between the glycosidic hydroxyl group of sialic acid and the two residues
E409 and Y530 are now lost, but these sidechains are stabilized by formation of an
intramolecular hydrogen bond. The hydrogen bonds between the sidechain hydroxyl
groups of sialic acid and E276 remained with DANA.
The binding of GANA to HN causes a reversal of certain effects observed in the
complex with DANA (figure 3.2C). The R192 sidechain guanidino group now moves
away from the carboxylate of GANA, but forms a stacking interaction with the latter‘s
guanidino group. The sidechain of Y530 now extends towards the guanidino group of
GANA, forming a hydrogen bond with it. T193 is also hydrogen bonded with the
guanidino group of GANA. All other interactions remain similar to those with DANA and
sialic acid. The structures of sialic acid, DANA and GANA bound to HN are shown in
figure 3.2.
Based on these interactions, it was clear that hydrogen bond acceptors were
desirable in the triarginyl region of the HN binding pocket, while a hydrogen bond donor
in the region where the GANA guanidino group is bound also increases affinity. Also,
the hydrogen bonds between the C7 and C9 of sialic acid were maintained throughout
the three structures of GANA and DANA with HN. These observations helped identify
key features of the pharmacophore for the creation of queries.
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3.4.2 Design of Queries
Two queries were designed based on the above pharmacophoric model. The
pyranose ring of GANA was defined as a hydrophobic center, which was surrounded by
three hydrogen bond donor features at the C7 and C9 hydroxyl groups and the
guanidino group. A negative center was defined in the vicinity of the carboxylate group.
The hydrophobic center was not defined for a query based on DANA, but was
supplemented with an acceptor atom in the vicinity of the pyranose oxygen. Also, an
acceptor atom and a steric feature were defined at the acetyl amino oxygen and methyl
group respectively. Both queries are delineated in figure 3.3.
3D flex searches were run on the ZINC database, which contained 3,820,641
compounds at the time when this work was performed. These searches utilize a
torsional minimizer in order to identify molecules which might adopt a conformation that
fits the query being used. Approximately 3000 hits were identified from the queries,
including a wide variety of chemical scaffolds.
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Figure 3.3 Queries on the ZINC Database. Orange spheres represent hydrophobic
centers. The following features were defined: DA, donor atom; HC, hydrophobic center;
NC, negative center; AA, acceptor atom; SF, steric feature.

3.4.3 Segregation of Drug-Like and Non Drug-Like Compounds
Not all the hits contained drug-like properties. Hence, these hits were carefully
screened for non drug-like properties. The molecules were segregated based on three
criteria: (1) drug-like versus non drug-like scaffolds and (2) Lipinski‘s rule of five.
3.4.3.1 Identification of drug-like and non drug-like scaffolds
Although the ZINC database is regularly used for virtual screening in order to
identify drugs, our hits contained a number of molecules which do not seem drug-like.
These molecules were identified by visual inspection and eliminated from further study.
A few examples of such hits are shown in figure 3.4.
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3.4.3.2 Lipinski’s rule of five
Lipinski published a set of rules which increase the chances of finding molecules
with favorable permeation and absorption characteristics which have been outlined in
Chapter 1 (vide supra). This set of rules has been implemented in the UNITY module of
Sybyl, which was used for datamining purposes in this project. The inbuilt molecular
screen identifies agents with less than 5 hydrogen bond donors and 10 hydrogen bond
acceptors. Moreover, it identifies molecules with a molecular weight less than 500 D
and a CLogP of less than 5.
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Figure 3.4 Structures Rejected by Visual Inspection. Some examples of molecules that were
deemed nondrug-like and excluded from further analysis.

After trimming the list of ligands using these criteria, 1513 compounds remained.
3.4.4 Docking
The ability to theoretically predict interactions between molecules based on
chemo-spatial considerations and the principles of physics has been of immense
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interest to scientists across the decades. Research across several decades has given
us multiple algorithms known as docking algorithms. Kuntz aptly described his docking
algorithm as a method to explore geometrically feasible alignments of ligands and
receptors of known structure [17]. The first examples of docking were perhaps those
published by Levinthal et al. in 1975 and Salemme in 1976 [18,19], describing attempts
at predicting structures of complexes in order to understand macromolecular
interactions. Kuntz‘s algorithm [17] was perhaps the first description of a program that
attempted to address docking of small molecules into proteins. This is a problem of
immense complexity due to the large number of degrees of freedom and the resultant
local minima an algorithm has to explore in order to obtain appropriate and accurate
predictions.
Several strategies have evolved in order to address this complex and
multifaceted problem, including incremental construction approaches such as FlexX
[20], shape-based algorithms such as DOCK [21], genetic algorithms such as
GOLD[22], systematic searches such as Glide [23], Monte Carlo simulations such as
LigandFit [24] and surface-based molecular similarity methods such as Surflex [25]. In
spite of the availability of several such algorithms, ligand docking does suffer from
several problems [26]. However, its utility in computational ligand design is undeniable,
especially due to the high benefit/cost ratio.
We utilized GOLD 3.0 to dock those hits which remained from visual inspection
of virtual screening results into the HN binding pocket. One hundred genetic algorithm
(GA) runs per compound were executed in order to obtain multiple poses of putative
114

ligands within the binding site. The total number of ligands remaining after visual
inspection of hits obtained from UNITY was 1513, thus resulting in 151,300 proteinligand complexes that needed to be scored.
3.4.5 Scoring of Docked Positions
The HINT forcefield [27,28] was used to score all protein-ligands complexes
obtained via docking because scores obtained from this forcefield are known to
correlate with binding free energy [29-32]. A list of top scoring compounds, along with
their ZINC codes, is displayed in appendix A. The crystallographic structures of HN with
Sialic Acid, GANA and DANA [15] showed HINT scores of 111, 1283 and 1673
respectively. These compounds were suggested for purchase and biochemical
evaluation. The decision to test these 137 compounds was based on the comparison of
HINT scores with those of the ligands bound to the crystal structures. An increase of
515 HINT units is associated with a 1kcal/mol increase in affinity; hence, many of these
structures were expected to be strong binders of HN.
3.5 PROBING ANTIVIRAL MECHANISM
Anne Moscona‘s group at Weill-Cornell Medical School tested 50 of the 137
compounds (vide supra) and found 17 inhibitors of HN. In order to probe the mechanism
of action of these inhibitors, a further docking study was conducted. Selected
compounds were docked into site II (vide infra) of HN.
Previous studies by the Moscona and Kellogg research groups had already
predicted the possibility of a second site on HN, which might interact with sialic acid
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containing receptors [33-35]. It has been shown that mutations on this site of HN can
cause premature triggering of the F-protein, thereby rendering the virus noninfectious
[35]. In order to probe the possible effects of one of the 17 inhibitors of HN
(ZINC02857325, Figure 3.5) identified by virtual screening, it was docked into site II and
the HINT scores were compared to those of GANA at both sites (table 3.1).
Table 3.1 HINT analysis of inhibitors at site I and II of HN
Compound
HINT Score
HPIV3 HN Site I
HPIV3 HN Site II
GANA
2769
660
ZINC02857325
2260
1108
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Based on these scores, it is possible that both GANA and ZINC02857325 will
bind site I of HN. However, it is possible that this compound will bind site II with a higher
affinity compared to GANA based on its HINT score at the same site. It has already
been shown that site II is resistant to GANA [33] and therefore validates our docking
results, therefore strengthening our belief that this compound might interact at site II of
HN.
Furthermore, in the best docked position of GANA at site II of HN the guanidino
group protrudes out of the protein into the surrounding medium and presumably
interacts with water (figure 3.6A). It is highly possible that this causes the ligand to be
solvated and thereafter vacates the binding site. It is possible that such an effect will not
be observed with the much more hydrophobic ZINC02817325.
3.6 PROBLEMS WITH DOCKING
Several cases were identified, in which the rotation of sidechains could improve
HINT scores. An example is delineated in figure 3.7.
This test case is a complex of ZINC02857325 docked into HN. The docked
position itself showed a HINT score of ~ -106. This was basically due to a clash between
the phenolic hydroxyl of Tyr337 and the sulfonamidic hydrogen. This situation could
easily be remedied by a simple rotation of the chi1 angle to alleviate the steric clash.
When this was performed manually, an additional hydrogen bond was formed between
the phenolic group of Tyr337 and the sulfonamidic hydrogen. This complex was then
rescored using HINT and an improvement of over 106 HINT units was observed. Of
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course, this was mostly due to the removal of the steric clash. An additional
improvement was also visible when a different rotamer of Lys254 was placed, causing
the formation of an additional H-bond between the triazole nitrogen and the protonated
amino group of the residue.
This example clearly indicates the possibility that docking may not be able to
accurately recreate the most probable binding pose for ligands without addressing
target flexibility. Even after minimization, which would alleviate steric clashes, there is a
chance that the most favorable binding pose may not be predicted because of the
nature of minimization algorithms; they are designed to traverse downwards along the
energy potential function and as a result will not overcome barriers in attaining the
global minimum. In essence, it is probably not realistic to expect identification of the
global minimum every time, but a reasonable investigation into target flexibility is
required. We suggest rotating residue sidechain chi angles as a method for exploring
induced fit.
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Figure 3.6 Interactions of GANA and ZINC02857325 with site II of HPIV3 HN. (A)
and (B) show the best docked positions of GANA and ZINC02857325 at site II of HN.
(C) shows the depth of both ligands; the guanidino group of GANA protrudes into the
surrounding environment, while the more hydrophobic ZINC02857325 shows no such
protrusion.
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3.7 SUMMARY
A virtual screening for inhibitors of HPIV3 HN was conducted using datamining
techniques, docking procedures and the HINT scoring function. This process identified
several inhibitors of the protein, which are as of yet being tested for their mode of action
in the Moscona laboratory at Weill Medical College of Cornell University. A 34%
success rate has been observed so far (calculated as number of compounds found
active for every 100 compounds tested experimentally).
It is common knowledge that virtual screening is, as of yet, only in its infancy; a
lot of work has to be done in order to improve the tools and procedures which are
currently in use. These problems [30] include a number of issues, such as protein and
ligand flexibility, role of water in binding and solvation, the combinatorial issue of
protonation/deprotonation of ligand and residues and perhaps the biggest problem of all
– scoring functions. Serious and long-term research needs to be performed in order to
address this multi-faceted problem.
In our quest to identify hits against HPIV3 HN, one problem we noticed was
target flexibility; although some docking programs already take this into account, this led
us to try and develop our own new tools. Chapter 4 addresses the current status of our
attempts in this direction.
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Figure 3.7 Rotation of residue sidechains improves docking scores. A situation is shown
where simple rotation of amino acid sidechains increased HINT scores for ZINC02857325
docked into site I of HPIV3 HN. This clearly indicates the possibility that the ―correct‖ binding
pose for this ligand may not have been identified.
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CHAPTER 4
SIDECHAIN OPTIMIZATION USING BACKBONE-DEPENDENT
ROTAMER LIBRARIES AND HINT
4.1 THE INDUCED FIT THEORY
In today‘s world of drug discovery/design that depends significantly on
understanding intermolecular interactions, the contributions of Emil Fischer and Daniel
Koshland are vital. Fischer first introduced the ―lock and key mechanism‖ in the late 19 th
century [1-2] and was revolutionary in many respects; it was perhaps the most important
description of enzymatic activity as a result of precise and specific intermolecular
interactions. However, theories are created in order to explain all facts known at the
time of their formulation and must be modified intermittently to include explanations for
all future discoveries that bring about discrepancies in them. Koshland wrote a review
on his modifications of Fischer‘s ―key-lock mechanism‖ in the late 20th century [3],
wherein he paid homage to the author while describing the then current status of his
―induced fit theory.‖ While Fischer‘s key-lock theory described enzyme activity in terms
of the analogy of a key fitting into a lock, thereby allowing the enzyme to act on it,
Koshland‘s theory specifically expounded on the importance of structural changes in the
protein at the same time. In his own words, the induced fit theory can be stated as ―a)
the precise orientation of catalytic groups is required for enzyme action, b) the substrate
causes an appreciable change in the three-dimensional relationship of the amino acids
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at the active site and c) the changes in the protein structure caused by the substrate will
bring the catalytic groups into the proper alignment, whereas a nonsubstrate will not.‖
4.2 EMULATING INDUCED FIT IN COMPUTATIONAL ALGORITHMS
The importance of induced-fit is not restricted to enzymatic activity, but also to
binding of non-competitive small molecule inhibitors or binding of drugs to nonenzymatic proteins such as GPCRs, as well as between interacting macromolecules.
Cozzini et al. describe the importance of the induced fit theory in drug discovery in their
perspective [4]. They describe multiple theoretical and experimental methods used to
explore induced fit in target-drug binding, laying special emphasis on the current status
of applications that take target flexibility into consideration during the drug
discovery/design procedure. The transition of molecular docking from its earliest
incarnations, in which rigid molecules were docked into a rigid receptor, to the current
algorithms and strategies employed to address this issue, has been described therein.
For example, a popular docking program Autodock [5-7] has the ability to explore
sidechain flexibility at the active site [8,9]. GOLD, FlexE, SLIDE and DOCK also use
algorithms in order to explore sidechain flexibility in a variety of ways [10-13].
Incorporation of target flexibility in such popular docking programs is indicative of the
importance of exploring induced fit in drug design endeavors.
4.2.1 Basic Structure of Algorithms for Emulating Target Flexibility
The degree of induced fit may vary between different protein-ligand interactions
and the introduction of even partial flexibility at the protein binding site is a challenging
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and computationally expensive task. This is especially true because exploring low
energy conformations of the protein is a combinatorial problem even when sidechain
flexibility alone is addressed. The overall algorithm for sidechain optimization can be
broken down into independent but equally important components: 1) selecting a method
for sidechain selection and positioning, 2) choice of a forcefield for evaluating sidechain
positions and 3) deciding an approach to solve the combinatorial problem of sorting
through the various permutations and combinations of sidechain positions in order to
achieve reasonable results.
4.3 DESIGNING OUR OWN ALGORITHM - THE COGS AND WHEELS
In order to create our own sidechain optimization method, in this work we explore
rotamer libraries as a source for sidechain coordinates. The choice of rotamer libraries
is a conscious one, based on the following reasons: 1) These libraries contain
coordinates for sidechain positions covering naturally occurring conformations and are
thereby likely to place residues in reasonable positions and 2) having preordained
positions for sidechains will probably translate into faster algorithms compared to
randomized placement methods (e.g., Monte Carlo methods or molecular dynamics
simulations) for achieving sidechain movement.
Several studies of sidechain rotamer distributions have been reported, including
those by James and Sielecki [14], Ponder and Richards [15], Janin et al [16], Dunbrack
and Karplus [17] and Dunbrack and Cohen [18]. These studies vary in scope and width;
for example, while James and Sielecki [14] described their findings about rotameric
127

preferences of residue sidechains from a single protein crystal structure, Ponder and
Richards [15] described the development of a complete rotamer library and an algorithm
meant to place sidechains on a protein backbone.
4.3.1 Rotamer Libraries
The different amino acid rotamer libraries in existence can be categorized as
backbone-dependent and backbone-independent.
4.3.1.1 Backbone-Independent Rotamer Libraries
The most important feature of backbone-independent rotamer libraries is that the
rotamer position is not related to the backbone geometry in any way. The Ponder and
Richards rotamer library [15] is an example of this category; the authors demonstrated
that only 67 sidechain rotamers are adequate to place 15 of the 18 naturally occurring
amino acid residues in which sidechain positioning is required (Ala and Gly do not fall
under this category). Met, Arg and Lys residues were not addressed in this study due to
their inherent flexibility. They used a rotamer library based on only 19 PDB files and a
simple van der Waal‘s term in order to pack these atoms.
Another example of a backbone independent rotamer library was reported by
Janin et al. [17] who, like Ponder and Richards, used a set of 19 PDB files as their
source data for calculations. They described the preferred conformations for several
protein sidechains. The fact that most of the χ1 angles for a variety of amino acid
residues coincided with two of three steric energy minima calculated for a blocked Lys

128

was interesting. A blocked Lys residue is defined as one that is allowed to rotate along
the Cα-Cβ bond to translate through χ1 angles, but all other χ angles are held constant.
It was clear from these studies that sidechain geometry is severely restricted for
a given main chain geometry. This fact is exemplified by the fact that more than 60% of
sidechains adopted only one or two rotameric positions [17]. Moreover, the number of
configurations adopted also depends on the position of the residue relative to the
protein surface. Also, the rotamers which are rare for a surface residue are even rarer
for an internal residue, implying a strong preference for certain values of the χ 1 angle.
Most importantly, steric energy was established as an important factor in sidechain
rotamer placement.
4.3.1.2 Backbone-Dependent Rotamer Libraries
The major difference between backbone-dependent and backbone-independent
rotamer libraries is the calculation of χ1 and χ2 probabilities as a function of Φ and Ψ
angles.
Dunbrack and Karplus introduced their sidechain optimization method based on
a backbone-dependent rotamer library [18] from a study based of 126 structures from
the Brookhaven Protein Database. The library was generated by assessing the
probability of χ angle values for a specific range of Φ and Ψ angles, i.e. the Φ and Ψ
angles were divided into bins incremented by 20˚ (0˚ to 20˚, 20˚ to 40˚, 40˚ to 80˚, etc.).
It was observed that several regions of the Φ, Ψ map were underpopulated due to
geometric restrictions on the backbone and the small bin size. For all amino acid
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residues except Ala, Pro and Gly, the χ1 values were binned into the -120˚ to 0˚, 0˚ to
120˚ and the 120˚ to -120˚ bins. Amongst the residues not covered, no χ values exist for
Ala and Gly due to the absence of the C atom. The same bin values were used for χ2
angle calculations for those residues where the χ2 angle exists, except for Pro, Asn,
Asp, Phe, Tyr and Trp. For Pro, the χ1 angle was binned only into two bins – positive
and negative values, corresponding to the two Pro conformations. The χ 2 angles for
Phe, Tyr and His were found to be mostly concentrated around the ±90˚ region, which
were treated as equivalent by adding 180˚ to any negative χ2 angles. These residues
show C2 symmetry across the C-C bond, which allows such equivalent treatment of
these rotamers. Again, Asp and Asn χ2 and χ2+180˚values were treated as equivalent
due to the symmetrical positions of the  atoms, but were binned into -90˚ to -30˚, 30˚ to
-30˚ and 30˚ to 90˚ divisions. Trp χ2 angles were binned into 0˚ to 180˚ and -180˚ to 0˚
because its rigid aromatic rings does not allow for more sterically favorable positions. χ 3
and χ4 angles were also binned for more flexible residues. Table 4.1 shows the χ1 and
χ2 bin limits described above. The probability of finding χ1 in each bin was calculated for
each Φ and Ψ bin combination. Similarly, the probability of finding χ2 in each of its bins
was calculated, given that χ1 was in one particular bin. This is usually designated as
χ1+2. Such binning and calculation of probabilities is the crux of backbone-dependent
rotamer libraries.
The authors observed specific preferences of sidechain conformations not only
for α-helices and β-sheets, but also for other regions. Mostly, residues preferred either
one sidechain conformation or else two nearly-equally favored conformations.
130

Dunbrack and Karplus designed a sidechain optimization algorithm using the
CHARMM forcefield and probabilities calculated by the above method. Overall, it was
observed that using backbone-dependent rotamer libraries enhanced the number of
correct sidechain predictions. When compared to an optimization method that utilizes a
backbone-independent rotamer library [19] it was found that most of the differences in
predictions were due to χ1 allocation.
Table 4.1. χ1 and χ2 bin limits are shown. These limits define the bin size during
probability calculations, which were made for each 120˚ bin of Φ and Ψ angles.
χ1 limits
χ2 limits
χ1 limits
χ2 limits
Lys, Arg, Met, Gln, Glu, Ile and Leu
Ser, Thr, Cys, Val, Phe, His and Tyr
0˚ to 120˚
0˚ to 120˚

0˚ to 120˚
120˚ to -120˚

0˚ to 120˚
120˚ to -120˚

0˚ to 120˚
120˚ to -120˚

-120˚ to 0˚
0˚ to 120˚

-120˚ to 0˚

120˚ to -120˚

120˚ to -120˚

0˚ to 60˚

-60˚ to 0˚

120˚ to -120˚

-120˚ to 0˚

-60˚ to 0˚

0˚ to 60˚

-120˚ to 0˚

0˚ to 120˚

-120˚ to 0˚

120˚ to -120˚

0˚ to 120˚

-90˚ to -30˚

-120˚ to 0˚

-120˚ to 0˚

0˚ to 120˚

-30˚ to 30˚

0˚ to 120˚

30˚ to 90˚

Pro

Asp and Asn

Trp
0˚ to 120˚

0˚ to 180˚

120˚ to -120˚

-90˚ to -30˚

0˚ to 120˚

-180˚ to 0˚

120˚ to -120˚

-30˚ to 30˚

120˚ to -120˚

0˚ to 180˚

120˚ to -120˚

30˚ to 90˚

120˚ to -120˚

-180˚ to 0˚

-120˚ to 0˚

-90˚ to -30˚

-120˚ to 0˚

0˚ to 180˚

-120˚ to 0˚

-30˚ to 30˚

-120˚ to 0˚

-180˚ to 0˚

-120˚ to 0˚

30˚ to 90˚

It was found that predicted sidechain positions were more accurate for buried
residues. The predictions were accurate for hydrophobic residues except Leu and
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aromatic residues except Trp. Cys residues were well predicted, perhaps because most
of these were present in pairs and formed disulfide bonds, which were specifically
identified before other sidechains were optimized. Thr sidechains were placed more
accurately compared to Ser, perhaps because there is less room for maneuvering due
to the presence of an extra C atom. Asp and Glu were least well placed by this
algorithm because these are mostly on the surface and have a lot more freedom to
move. Moreover, contacts between successive units which exist in crystals were
completely ignored in the optimization process.
Dunbrack and Cohen introduced an enhanced version of the Dunbrack and
Karplus backbone-dependent rotamer library in 1997. They used Bayesian statistics in
order to address the likelihood of obtaining one rotamer, given an original probability
distribution similar to that of the Dunbrack and Karplus rotamer library. The analysis was
simple in terms of assumptions; only one was employed – that the probability of one
particular dihedral is dependent only on the value of the previous dihedral. For example,
the probability of obtaining a χ1 value depends on what the Φ and Ψ dihedrals are.
Likewise, the probability of obtaining a particular χ2 value depends only on what the χ1
value is. The same assumption can be made for χ3 and χ4 as well. Using this rotamer
library, Bower, Cohen and Dunbrack created a sidechain optimization algorithm SCWRL [20].
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4.3.2 Choice of Scoring Function
Traditionally, sidechain optimization algorithms have employed scoring functions
that pack atoms together. This is especially advantageous because the function of
these packing methods is quite complementary to the nature of crystal structures – in
both cases, atoms are packed as tightly together as possible. However, such packing
algorithms usually overlook phenomena such as electrostatic interactions, hydrophobic
interactions, H-bond formation and pi-cation interactions.
One obvious improvement in such algorithms would be to explore the effect of
force fields that can address these currently neglected interactions. We decided to use
our in-house HINT scoring function [21,22]. Our hypothesis is that HINT will be
complementary to steric-based potential functions for a number of reasons: (A) HINT
employs a van der Waal‘s interaction function quite similar to the steric-based LennardJones potential of SCWRL-like programs, (B) HINT addresses hydrophobic interactions,
which have been shown to depend on surface area contacts [23,24], which is quite
similar to traditional contact-based scoring functions and as explained above, (C) HINT
takes several different types of interactions such as hydrogen bonding into account,
while packing methods do not share this capability.
4.4 THE SCWRL ALGORITHM
Dunbrack‘s group introduced a popular program called SCWRL [20] (SideChain
optimization With Rotamer Libraries) whose main aim was to predict crystal structure
sidechain positions, given the backbone coordinates. This program was based on a
133

backbone-dependent rotamer library [18] and employed a modified Lennard-Jones
potential equation for energy calculation purposes. In order to solve the combinatorial
problem of parsing through rotamers, each sidechain is initially placed in its most
favorable rotamer and clashes are identified as those residues which exceed a cutoff
value for the steric potential. ―Clusters‖ of clashing residues are identified as those that
clash with each other and are solved by a combinatorial parsing of rotamer
permutations and combinations.
4.4.1 SCWRL “Successfully” Identifies “Correct” Sidechain Positions
Dunbrack et al. have shown considerable success in identification of sidechain
positions, if provided with the coordinates of backbone atoms [20]. The structure of this
algorithm is highlighted below.
4.4.1.1 Initial Sidechain Rotamer Placement
The initial step used by SCWRL is very simple: after the backbone atoms have
been read in, it places the sidechain atoms in their most probable form which does not
clash with the backbone. Backbone clashes are detected by using a modified (linear)
van der Waal‘s equation, which calculates a minimum value of 0 kcal/mol for no steric
interaction or 10,000 kcal/mol for steric clashes. Favorable van der Waal‘s interactions
were sacrificed to improve search speed.
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4.4.1.2 “Cluster” Parsing Method
―Clusters‖ of clashing residues are identified and solved by a combinatorial
parsing of rotamer permutations and combinations, intermittently employing a clusterdividing technique if the number of residues within a ―cluster‖ exceeds 15 residues. In a
case where the number of residues does exceed this number, the residue whose
sidechain has most clashes is identified and placed in its most probable position which
does not clash with the backbone, thereby dividing the large cluster into smaller clusters
that are more easily manageable. Each such division of the large cluster is then treated
as a smaller cluster and a combinatorial search for sterically favorable sidechain
rotamers is conducted. A favorable combination of rotamers is defined as one which
has zero steric energy, as decided by the modified Lennard Jones potential equation.
However, if no such combination is found, the set of rotamers showing lowest steric
clashes is selected.
4.4.1.3 Criteria for “Success”
The authors of the SCWRL program compare χ1 angles directly with the original
PDB files in order to measure the success of their algorithm. However, their metric for
comparison is whether the program correctly identifies this dihedral angle within ±40˚ of
the actual χ1 value from the original crystal structure. However, seeing that it uses
backbone-dependent rotamer libraries, which are essentially programmed with the
probabilities of χ angles existing given the Φ and Ψ angles of the backbone, it is hardly
surprising that these angles were successfully predicted. Moreover, the χ 2 angles are
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only compared for those cases in which χ1 angles are ―correctly‖ predicted (χ1+2
predictions).
Overall it was shown that the χ1 angle was correctly predicted 77% of the time,
while χ1+2 predictions were correct on 66% occasions. The percent correct predictions
varied between different types of amino acid residues. For aromatic residues such as
Phe and Tyr, the χ1 determination was 90% accurate. SCWRL also accurately predicted
the χ1 values for residues with β- and - branched sidechains such as Val, Thr, Ile, Leu,
His and Trp (>80% correct). SCWRL performed less well with Ser and those residues
with long unbranched sidechains such as Met, Glu, Gln, Arg and Lys (60 to 72%
correct). The χ1 values for both Asp and Asn were predicted correctly over 73% of the
time. An evaluation of χ2 prediction showed that the degree of accuracy was lower than
that for χ1. However, this is expected because SCWRL is a method that depends on
packing. As the distance of a sidechain atom from the backbone increases, the ability of
the atom to move also increases due to lower steric interactions with the backbone. It
can hardly be expected that the atoms responsible for the χ 2 dihedral angle will be
packed as tightly as the C atom unless these are completely buried within the bulk of
the protein.
4.4.2 Can the HINT Scoring Function Complement the SCWRL Rotamer Library?
The ability of SCWRL to predict correct sidechain positions in crystal structures
perhaps can, at least partially, be attributed to the inclusion of rotamer probabilities.
When conducting molecular modeling or drug discovery studies, it becomes more
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important to study proteins in their native state, e.g., the dominant state of a cytosolic
protein in an aqueous environment. This cannot be achieved by using SCWRL‘s
modified Lennard-Jones potential scoring function, because it completely ignores intraprotein interactions other than sterics. In accordance with our long term goal of creating
an algorithm that can simulate sidechain flexibility in docked structures, we decided to
test the compatibility between Dunbrack‘s backbone-dependent rotamer library [18] and
the HINT scoring function, which should theoretically be able to address those
interactions within the protein that are completely neglected by SCWRL. However, it
must be noted here that the newest version of SCWRL (ver. 4.0 [25]) is capable of Hbond detection. The results of our pilot study aimed to analyze whether or not the
SCWRL 1.0 rotamer library is compatible with the HINT scoring function are reported
herein.
One way of approaching this question is to try to emulate SCWRL‘s original
function of sidechain prediction for known crystal structures. If the HINT scoring function
is at least as successful as SCWRL, or even if it comes close to doing so, we can
perhaps safely conclude that HINT may be used to complement the SCWRL backbonedependent rotamer library, or, in other words, that these two technologies are
synergistic in molecular model-building applications.
4.5 THE HINTASCWRL ALGORITHM
The HINTaSCWRL (HINT assisted SCWRL/Hydropathic INTeractions Assisted
SideChain optimization With Rotamer Libraries) Algorithm was designed using a
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backbone-dependent rotamer library and a hydropathic forcefield, whose pseudocode is
described below:

Read input PDB
Select protein from PDB
Calculate Φ and Ψ angles
Get χ values from sidechain data
Build multiple sidechain conformations for all residues
Check all rotamers for backbone clashes
Find best rotamer
{
for all residues
{
Add Hydrogens
For each rotamer with no backbone clashes
{
Calculate HINTaSCWRL score
Keep rotamer with highest HINTaSCWRL score
}
}
}
Perform second round of optimization
Delete any Hydrogens present
Write output PDB
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The program was written in C, using the HINT toolkit and the backbonedependent rotamer library from SCWRL 1.0 (referred as SCWRL hereon). The
algorithms are still in a very preliminary state and come with no additional features
aimed at improving prediction capabilities; no mathematical strategies have been
adopted in order to solve combinatorial issues, nor has any special modification been
made in order to obtain optimum predictions. Indeed, this is the very first form of our
protocol, which will need many cycles of refinement in order to improve its functioning.
4.5.1 The Backbone-Dependent Rotamer Library
HINTaSCWRL employs the same backbone-dependent rotamer library as
SCWRL. The selection of the Cohen-Dunbrak backbone-dependent rotamer library was
chosen in order to enable direct comparison with SCWRL generated sidechain
positions.
4.5.2 The HINTaSCWRL Scoring Function
The HINTaSCWRL scoring function that was employed in this program can
mathematically be denoted as follows:

The Log values of probabilities were taken because that linearizes the data.
However, this caused a problem because probability values were all fractional and
yielded negative values when converted to Log form, thereby reversing the sign
(favorable/unfavorable) of the final score that should be supplied by HINT. This problem
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is easily solved by normalizing against log(probability) of the most probable rotamer.
This also allows us to measure the comparative likelihood of obtaining the current
rotamer against the most probable rotamer.
A similar approach where the probability of the current rotamer was multiplied
with its HINT score was also considered, but was not found to be as useful as the above
scoring function because a few rotamers were frequently found to be several times
more probable than all other rotamers combined. This caused probability to dominate
the decision making process, thus making the HINT score virtually redundant (except in
the case of a sign change facilitated by it). Additionally, it effectively reduced the
conformational space explored because the lowest probability conformations (with
probabilities ranging up to the 10-6 region) were virtually never considered.
4.5.3 Sorting Through Clashes and Bad Interactions
After the initial placement of sidechains, the residues with the worst scores were
identified and optimized a second time. While the initial placement of sidechains took
probability into account, this time only the HINT score was used.
4.6 THE TEST SET
A data set of 129 PDB files containing no ligands and with resolutions between 11.5 Å were downloaded from the RSCB Protein Data Bank and prepared by removal of
all alternative conformations for sidechains. The PDB list is as follows:
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2BCM, 2BN3, 2BOG, 2BZV, 2CG7, 2CIT, 2CL2, 2CYG, 2DF6, 2DPL, 2E0Q, 2E10,
2E3H, 2E3Z, 2ERF, 2ERW, 2FHZ, 2FQ3, 2FR2, 2FRG, 2FWG, 2G69, 2G7O, 2GBJ,
2GEC, 2GKG, 2GKT, 2GOM, 2GQV, 2GRC, 2GUV, 2GXG, 2GZV, 2H3L, 2H8E, 2HLR,
2I3F, 2IBL, 2IC6, 2ICC, 2IGD, 2IPR, 2IVY, 2IWN, 2IXM, 2J6B, 2J73, 2J8B, 2JCP, 2JIC,
2JLJ, 2LIS, 2NRR, 2NWD, 2O37, 2OCT, 2OEI, 2OHW, 2OKT, 2OLX, 2OVA, 2OZF,
2P4H, 2PMR, 2PND, 2PPO, 2PV2, 2QHT, 2QOL, 2QT4, 2QVK, 2R6Q, 2RB8, 2RK3,
2RK5, 2VC8, 2VIM, 2VY8, 2W1R, 2W2A, 2W6A, 2WJ5, 2WLV, 2YXF, 2YZ1, 2ZO6,
3A7L, 3BA1, 3BB7, 3BOI, 3BPV, 3BQS, 3BZT, 3BZZ, 3C8P, 3CA7, 3CJW, 3CKF,
3CT5, 3CTG, 3CX2, 3CZZ, 3D9X, 3DFG, 3DS4, 3DWV, 3EVP, 3EXV, 3EY6, 3EYE,
3FKE, 3FPO, 3FTD, 3FTK, 3FVA, 3HFO, 3HNX, 3HNY, 3HZ8, 3I4O, 3IVV, 3KB5,
3KGK, 3KJT, 3KTP, 3L32, 3L3E, 4EUG and 4PTI.
The algorithm was not trained on any of these structures, which contain up to
919 residues.
4.7 HINTASCWRL OUTPUT ANALYSIS
Since the main aim of this project was to test the ability to use the HINT forcefield
with rotamer libraries and not necessarily to improve sidechain placement algorithms
such as SCWRL, the most important aim of the HINTaSCWRL algorithm is to predict
structures approximately as well as SCWRL. If this were true, it would demonstrate the
ability to use HINT in conjunction with rotamer libraries. On the other hand, it would
definitely be advantageous if we could improve sidechain predictions. With these aims
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in mind, the output of HINTaSCWRL will be compared with the same from SCWRL
through the rest of this chapter.
4.7.1 Analysis of Sidechain RMSD
The RMSD for each sidechain of the HINTaSCWRL and SCWRL output PDBs
from the original PDB were calculated. Figure 4.1 shows line plots of RMSD for all
residue sidechains across all 177 test structures. The first column consists of RMSD for
each amino acid residue for HINTaSCWRL output PDB files, while the second column
shows the same for SCWRL output files. The third column shows an RMSD difference
between HINTaSCWRL and SCWRL output files. It must be noted at this point that
these residues have been sorted in order of their solvent accessible surface area
(SASA) before the plots were generated.
HINTaSCWRL results – Cys, Pro, Ser, Thr and Val residues showed the lowest
deviation (up to 1.5 Å) from the original PDB, while Asn, Asp, Gln, Glu, Ile, Leu and Met
showed a higher RMSD value (up to 2.5 Å) in comparison. Arg, His, Lys, Trp and Tyr
showed the highest deviations (up to 5 Å) from the original crystal structures.
Comparison with SCWRL output files – All amino acid residues showed similar
deviations from the original PDB, as is witnessed by the similarity between the first two
columns (Figure 4.1). The third column shows the deviation of HINTaSCWRL output
structures from SCWRL predicted ones. Most of the residues show very low to no
deviation, which means that the output structures are extremely similar to each other.
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Figure 4.1 RMSD values for individual amino acid residue sidechains. (A) RMSD
for HINTaSCWRL output PDB files (B) RMSD for SCWRL output. (C) RMSD between
HINTaSCWRL and SCWRL output files.
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Figure 4.1 continued.
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Figure 4.1 Continued
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Figure 4.1 continued
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Figure 4.1 continued.

4.7.2 RMSD as a Function of Solvent Accessible Surface Area
Figure 4.2 shows RMSD of amino acid residue types as a function of Log(SASA)
in HINTaSCWRL predicted structures. A prominent increase in the RMSD of residues is
observed with increase in SASA. Therefore, residues closer to the outer surface of a
protein have higher solvent accessibility. Such residues which are closer to the outer
surface have a higher degree of steric freedom, resulting in poorer predictions.
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Figure 4.2 RMSD as a function of Log(SASA) in HINTaSCWRL output files.
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Figure 4.2 continued
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Poor predictability is expected in these cases; solvent accessible residues would
have a higher degree of movement in their native environment. Hence, the inability of
HINTaSCWRL to predict exact positions for these residues does not raise any
concerns. However, Phe, Tyr and Trp show a regular trend of poor predictions
irrespective of the SASA of any particular residue, but the increased incidence of poor
predictions with increase in SASA is clearly visible in these residues.
The trend of increased RMSD compared with original PDBs is clearly visible in
figure 4.3, where RMSD for all residues has been plotted against their SASA for both
HINTaSCWRL and SCWRL predicted structures.
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Figure 4.3 Overall RMSD across all residues as a function of Log(SASA). (A) is for
the HINTaSCWRL output structures, while (B) shows the same data for SCWRL
predicted structures.
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4.7.3 Analysis of Average RMSD per Residue Type
The plot of average RMSD for each residue type in each structure is shown in
figure 4.4. The red lines depict average RMSD for each residue type in HINTaSCWRL
generated output structures, while the same for SCWRL output files are illustrated with
a blue line. While smaller residues such as Cys, Ile, Leu, Ser, Thr and Val, along with
sterically restricted residues like Pro, demonstrate lower average RMSD values, others
such as Arg show a much higher value.
The higher average RMSD value for hydrophilic residues such as Arg, Lys, His,
Asp, Glu, Asn and Gln is expected because they are usually found on the solvated
surfaces of proteins. However, aromatic residues Phe, Tyr and Trp show a range of
average RMSD values; from high to low. This could possibly be because of their
equivocal distribution; they exist on the surface of proteins and also in their bulk. This
would explain why these residues demonstrate a wide range of average RMSD values.
It is remarkable that all types of amino acid residues show very similar average
RMSD value for both HINTaSCWRL as well as SCWRL.
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Figure 4.4 Average RMSD for each type of amino acid residue. HINTaSCWRL
output is depicted by the red line, while SCWRL output is shown in blue.
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4.8 SELECTED HINTASCWRL OUTPUT STRUCTURES
4.8.1 Specific Case Studies
Considering the aims of this project, it is of immense interest to compare the
output structures of HINTaSCWRL and SCWRL with the original PDB and then to
compare both output structures to each other. This will tell us how successful either
program is in predicting sidechain positions. More importantly, since we are mainly
interested in assessing the compatibility between Dunbrack‘s rotamer library and the
HINT scoring function, we would ideally like to see similar predictions by both
algorithms. It would be even better if HINTaSCWRL is able to predict structures that are
closer to the original PDB.
Thus, the minimum expectations from the structures predicted by our algorithm in
order to claim success are: (A) the structures should be very close to the SCWRL
predicted structures, unless they are closer to the original PDB and (B) most of the
deviations should be localized near the surface of the structures, where residues enjoy
a greater steric freedom that allows greater movement. Three randomly chosen protein
structure predictions are presented with these aims in mind.
Only a few residues show a high RMSD in both HINTaSCWRL and SCWRL
programs, designated in red, while most residues have a low RMSD. For 2CYG, the
predicted residue positions are exactly the same for both programs, as visible by the
entirely green color in figure 4.5 (C). In retrospect, the output created by both programs
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were not always exactly the same and varied to a certain degree, as is visible from
figure 4.5 (F) and (I). However, the similarity between the two programs is striking
despite a small degree of differences.
The degree of structural deviation is described by the plots of RMSD for each
structure in figure 4.6. While parts (A), (C) and (E) show plots of RMSD for each residue
when compared with the original crystal structure, (B), (D) and (F) show the how much
the two output structures deviate from each other.
Both algorithms show similar RMSD profiles when compared to the original PDB,
as witnessed in figure 4.6 (A), (C) and (E). In two of the three test cases showed here,
the structures produced by HINTaSCWRL and SCWRL are very similar to each other.
However, these two algorithms predicted vastly different structures for 4EUG, as shown
by figure 4.6 (F). A visual inspection of the structure of 4EUG demonstrated that most of
the RMSD between the output structures predicted by both algorithms was due to
residues on the surface of the protein, shown in figure 4.5 (I) and hence is quite
acceptable.
While there was no difference between the HINTaSCWRL and SCWRL output
structures for 2CYG, there were differences between the same for 2VC8 and 4EUG.
The residues with the largest RMSD values for both 2VC8 and 4EUG were identified:
Asn13 for 2VC8 and Lys171, which were both found to be on the surface. A close
inspection of these two residues showed differences in interactions. While Lys171 for
the HINTaSCWRL output structure showed formation of an extra H-bond, as observed
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Figure 4.6 RMSD values plotted for each residue of 2CYG, 2VC8 and 4EUG in the
first, second and third rows respectively. (A) (C) and (E) show RMSD values for
HINTaSCWRL and SCWRL predicted structures in red and blue respectively. (B) (D)
and (F) show deviations between the structures predicted by both programs in green.
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in figure 4.7 (B). Interestingly, as is visible in figure 4.7 (A), Asn13 in the SCWRL output
structure showed formation of an extra H-bond, which was unexpected. In contrast, the
HINTaSCWRL output structure avoided bad hydrophobic-hydrophilic interactions with a
nearby Ile. The formation of an additional H-bond in Asn13 within the SCWRL output
structure must be a coincidence because this program only considers van der Waal‘s
interactions.
4.9 CONCLUSIONS
The performance of our algorithm was comparable to that of SCWRL. The trend of
RMSD distribution across 129 high resolution structures was similar for both programs,
as was the dependence of RMSD values on solvent accessibility of the residue
involved. It is remarkable that a number of residues were predicted very near their
native conformations in the original PDB itself, as was shown by the random test cases
(vide supra). It was observed that our algorithm would select different conformations of
residue sidechains when it detected energetically favorable interactions that were not
detected by SCWRL. The RMSD profiles of SCWRL and HINTaSCWRL predicted
structures were similar to each other. In two of the three cases, both algorithms
predicted very similar positions for all sidechains. However, there was one case in
which the predictions were notably different. On the other hand, it was clearly shown
that the all the residues which were predicted differently by the two algorithms existed
on the surface of the proteins. Thus, this was not a concern because the higher steric
freedom afforded to the surface residues allows movement and thus deviation is
expected.
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Figure 4.7 Positions of Sidechain Showing Highest Deviation. (A) Asn13 of 2VC8 in
the SCWRL structure shows an extra H-bond while the same in the HINTaSCWRL
structure shows none. (B) Lys171 of the HINTaSCWRL structure shows an additional
H-bond compared with the same in the SCWRL predicted structure.
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With these facts in mind, we may again ask ourselves: Are we able to emulate
SCWRL and its ability to optimize sidechains? Since the structures predicted by both
algorithms are very close to each other, with the major deviations isolated on the
surface of the protein, we can assuredly say yes! We cannot, however, make a claim
about improving sidechain prediction capabilities of SCWRL, at least with regard to
emulating crystal structures.
However, the major aim of this project was not to emulate or improve sidechain
optimization already provided by SCWRL, but to ascertain the ability to use HINT in
conjunction with backbone-dependent rotamer libraries. Since the output structures
obtained from our algorithm were extremely close to those produced by SCWRL and
the differences were ascertained in the sample test cases to be caused by improved
interactions, we have successfully fulfilled this aim.
At the same time, this project is still in its infancy. Therefore, we must stress the
possibility that further experimentation with the sidechain placement algorithm and
scoring function could possibly provide us with much improved sidechain placement.
4.10 FUTURE DIRECTIONS
With the implementation of the HINTaSCWRL algorithm, the compatibility
between HINT and sidechain rotamer libraries has been established. The next stage of
this project will be to create an algorithm that optimizes residue sidechains in the
immediate vicinity of docked ligands. This new algorithm will be somewhat different from
the current state of HINTaSCWRL because at present the latter only considers
162

interactions within the protein; the sidechain positioning in the next stage will have to
balance intra-protein interactions with protein-ligand interactions. Moreover, the role of
backbone-dependent vs. backbone-independent rotamer libraries in such an algorithm
will have to be investigated.
Simultaneously, modifications in the sidechain placement strategy and scoring
function must be explored in order to attempt improvement of the algorithm itself. The
scaling of steric and hydropathic components of the HINT score is one possible avenue
for exploration. This will be an interesting avenue to explore because packing methods
have traditionally been adequate to place sidechains in algorithms such as SCWRL.
Packing methods (i.e., using steric potentials such as the Lennard-Jones potential
function and its variants) have proven to be especially useful due to the ease of
implementation and enhanced speed of execution, thereby providing reasonable results
within shorter runtimes. In contrast, a scoring function such as HINT takes longer to
execute. However, it can account for several other kinds of interactions other than (and
including) sterics. This should, at least in theory, allow better sidechain placement
compared to algorithms that employ simple Lennard-Jones potentials.
Furthermore, weighting the probability factor could possibly enhance the quality
of sidechain optimization. However, it is unlikely that simple modulation of the HINT
score and probability factors alone will allow better emulation of crystal structures
(compared to SCWRL), especially if the sidechain positions are being provided by a
rotamer library. Unless such rotamer libraries are exhaustive, it might be difficult to
cover sufficient conformational space to achieve highly accurate predictions. Thus,
163

sidechains might have to be rotated, in which case a strategy will have to be devised to
overcome the combinatorial explosion which is imminent. This strategy can perhaps
also be implemented during resolution of sidechain clashes.
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CHAPTER 5
CONCLUSIONS
Hydrophobicity impacts every aspect of drug design and even delivery, as has
been repeatedly pointed out over the past century and within this dissertation. Studies
of this phenomenon have resulted in multiple theories, algorithms and tools for applying
the concept. A large amount of effort has been put forth into studying the partition
coefficient both experimentally, especially in terms of its prediction because of its
importance in ―druggability‖ of compounds. Many theoretical methods are robust in
estimating LogP for molecules similar to their training set, but large errors are fairly
common for compounds with large chemical and structural differences from that set.
Since Hansch and Fujita introduced the QSAR method, drug design projects
have repeatedly found use for hydrophobic parameters.

This dependence of drug

design on lipophilicity is intuitive, arising from drugs and proteins coming together, or
proteins folding, in order to reduce the surface area in contact with polar water
molecules.

Quantification of this phenomenon has taken many forms, such as

calculating of hydrophobic surface contact area to represent hydrophobic interactions,
supplementing 3D QSAR with hydrophobic fields (HINT and MLP) [1-3] and direct
quantification of intermolecular interactions with HINT [4-8]. While there are numerous
force fields available, most are Newtonian in origin and concentrate on H-bonding,
Coulombic interactions, van der Waal‘s interactions and London forces for estimating
the strength of molecular interactions, all of which are mostly if not entirely enthalpic.
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HINT is different in that it accounts for both hydrophobic and hydrophilic interactions
and is therefore representative of enthalpic, as well as that of entropic contributions
towards biological interactions, being derived from a free energy experiment.

The

availability of the HINT toolkit [9] makes it possible to develop application programs for
computer-aided drug discovery and design.
In this work, we presented current state of the projects aimed at exploring our
hypothesis that most biological phenomena can be explained by addressing
hydrophobic and hydrophilic interactions. The efflux pump project best epitomized the
validity of this hypothesis. While the HINT force field has been successfully
implemented in characterizing binding of small molecules to macromolecular targets
and also intermacromolecular interactions in the past [4-8], these multidrug transporters
posed a significantly different and complex challenge. The very fact that these huge
proteins do not just bind small molecules, but transport them, was the root of this
challenge. In theory, any such transport mechanism should be addressable by treating it
as a series of consecutive and independent binding events. In accordance with this, we
devised a method where HINT scores (representing these consecutive binding events)
were used to successfully predict MIC ratios of multiple antibiotics of various classes, in
conjunction with certain properties of the antibiotics themselves. It was found that LogP
was a major contributor in the statistical models generated therein. However, the same
descriptor alone was insufficient to achieve the same degree of predictability. More
importantly, LogP itself is a measure of the efflux substrates hydrophobic nature and its
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contribution towards the final model represents another way in which hydrophobic
interactions might affect biomolecular phenomena and thereby supports our hypothesis.
The third chapter described our attempts at discovery of antiviral agents, which
resulted in identification of several interesting compounds, of which 34% were found to
inhibit hemagglutinin-neuraminidase. This project produced only moderate success
rates, partly due to some problems with the tools employed therein – particularly the
inability of docking methods to effectively address induced-fit during binding of small
molecules. We chose to design new in-house tools in order to address these problems
in the long run and have presented our preliminary investigation towards establishing
feasibility of the project herein. Our studies showed that even at the simplest level of
implementation, the HINT scoring function successfully placed sidechains for residues,
given the backbone coordinates, which is another example where our hypothesis
appears to be true. It must be admitted though, that work on this project has only just
begun and a lot more needs to be done before we can claim that our hypothesis is true
beyond doubt in the context of this project. With the results of this project in mind, we
have chosen rotamer libraries and the HINT scoring function as our basis for design of
new tools to simulate target flexibility. Further attempts at optimizing the sidechain
optimization algorithm will also continue. It is generally accepted that proteins fold in
such a way that hydrophobic groups are largely shielded from water by hydrophilic
groups. While evaluating the factors that affect prediction of protein folds, Park et al.
noted that hydrophobicity of residues is the largest force defining protein structure, but
that other factors were involved as well [10]. Accurate hydrophobicity measurements
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and estimation of hydrophobic interactions could therefore have a tremendous impact
on the modeling of not only protein folding, but also side chain orientation.

Better

modeling and representation of both protein folding as well as side chain positioning,
will also contribute to the understanding of biological processes which are significantly
altered by macromolecular flexibility.
Overall, good progress was made towards the implementation of our hydropathic
force field in predictive model building and the design of new tools. There is no doubt in
our mind that application of this methodology in computational life sciences and
computer-aided drug design will lead to accurate theoretical prediction of biological
phenomena. The complex phenomena of hydrophobicity and hydrophobic interactions
are still only poorly understood and remain quite difficult to simulate. However,
understanding and exploiting the hydrophobic effect in drug design, e.g., docking, target
structure prediction, etc., will undoubtedly be increasingly important in the future.
Hydrophobicity may not be the ―Holy Grail‖ of biomolecular phenomena, but it is
definitely the one of the ―Commandments‖.
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APPENDICES
Appendix A
List of Hits from Virtual Screening for Hemagglutinin-Neuraminidase Inhibitors
ZINC ID
ZINC04552407
ZINC04533949
ZINC01530138
ZINC04825403
ZINC01737956
ZINC02384787
ZINC03873854
ZINC03873852
ZINC03873853
ZINC03873185
ZINC03873855
ZINC04544949
ZINC04545884
ZINC02390911
ZINC03871260
ZINC03830892
ZINC04899504
ZINC01529261
ZINC03873184
ZINC05274030
ZINC04544668
ZINC04556739
ZINC05295094
ZINC03873183
ZINC04556499
ZINC03014483
ZINC04899413
ZINC02508221
ZINC05274031
ZINC03870127
ZINC04533780
ZINC05274029
ZINC04533783
ZINC04214182
ZINC03873186
ZINC03830893
ZINC04556495
ZINC04533725
ZINC02390912
ZINC03871275
ZINC03873187

HINT Score
6783.014
6772.188
6701.919
6504.188
6410.739
6387.623
6317.374
6260.759
6125.606
6120.066
5931.146
5902.57
5895.988
5886.638
5865.923
5855
5842.17
5760.611
5660.111
5658.885
5558.37
5543.093
5479.984
5478.967
5465.758
5445.177
5437.815
5420.523
5374.107
5365.563
5351.754
5350.48
5330.799
5325.671
5316.4
5265.247
5250.292
5241.01
5217.136
5209.737
5182.773
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Database
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich

ZINC05273655
ZINC04533726
ZINC03830452
ZINC01569744
ZINC03873182
ZINC03871276
ZINC03873188
ZINC01575534
ZINC02384673
ZINC00236772
ZINC04556815
ZINC04533731
ZINC04552406
ZINC02707649
ZINC05274037
ZINC03869424
ZINC03014482
ZINC04531662
ZINC05257890
ZINC04820544
ZINC04106683
ZINC05274006
ZINC01607828
ZINC05257957
ZINC05257889
ZINC04556493
ZINC04533734
ZINC03872461
ZINC04533843
ZINC03873181
ZINC01210754
ZINC05273546
ZINC03871263
ZINC02575474
ZINC04533732
ZINC04939701
ZINC04533735
ZINC03870005
ZINC05274008
ZINC03872463
ZINC04760528
ZINC04544665
ZINC04511392
ZINC04514036
ZINC04513860
ZINC04556886
ZINC04543872

5153.94
5144.388
5120.193
5117.354
5082.202
4990.011
4983.702
4962.166
4912.327
4869.534
4853.672
4853.62
4840.231
4832.24
4823.205
4815.127
4809.821
4791.451
4786.626
4744.787
4699.967
4696.594
4689.038
4688.907
4684.735
4681.904
4643.627
4643.069
4641.547
4634.583
4615.563
4585.158
4572.668
4554.932
4552.692
4546.525
4496.596
4465.234
4386.57
4378.871
4363.481
4358.829
4318.523
4302.86
4294.716
4291.104
4283.146
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Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Vitas
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
LifeChemicals
Sigma Aldrich
Keyorganics
Sigma Aldrich
Sigma Aldrich
LifeChemicals
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Vitas
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Asinex
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich

ZINC05273678
ZINC04566466
ZINC06142968
ZINC01893413
ZINC04739725
ZINC04566465
ZINC05273548
ZINC05511105
ZINC01638013
ZINC04533969
ZINC04024388
ZINC04291876
ZINC04291877
ZINC03872462
ZINC04099087
ZINC03999322
ZINC01607692
ZINC05260452
ZINC04557073
ZINC03869383
ZINC02575489
ZINC04514038
ZINC04556887
ZINC04545848
ZINC04544666
ZINC02685419
ZINC04159200
ZINC04533971
ZINC05511098
ZINC02685397
ZINC02685329
ZINC02685344
ZINC04535978
ZINC03871262
ZINC02685352
ZINC05545049
ZINC05273579
ZINC04514042
ZINC01893410
ZINC00236768
ZINC01805621
ZINC02685380
ZINC00574780
ZINC04040894
ZINC05511073
ZINC05260460
ZINC04660887

4276.885
4269.913
4261.341
4243.928
4236.693
4205.4
4201.266
4191.064
4186.778
4184.555
4177.399
4159.401
4154.487
4152.638
4145.463
4136.824
4134.645
4134.227
4121.642
4119.558
4091.542
4079.696
4048.887
4048.283
4045.601
4044.966
4032.111
4030.039
4024.855
4023.99
4003.465
3997.909
3996.699
3987.519
3980.843
3971.142
3967.291
3961.863
3958.873
3958.214
3951.552
3927.787
3927.28
3923.655
3918.173
3916.985
3913.51
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Sigma Aldrich
Sigma Aldrich
Otava
Otava
Vitas
Sigma Aldrich
Sigma Aldrich
Otava
Sigma Aldrich
Sigma Aldrich
Keyorganics
LifeChemicals
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
LifeChemicals
LifeChemicals
Sigma Aldrich
Otava
LifeChemicals
LifeChemicals
LifeChemicals
Sigma Aldrich
Sigma Aldrich
LifeChemicals
Otava
Sigma Aldrich
Sigma Aldrich
Otava
Vitas
LifeChemicals
LifeChemicals
Vitas
Keyorganics
Otava
Sigma Aldrich
Otava

ZINC05273547
ZINC01893416
ZINC00816404
ZINC01576098
ZINC02685391
ZINC04507507
ZINC05274009
ZINC03394329
ZINC04556744
ZINC04513863
ZINC04533809
ZINC04521828
ZINC06143684
ZINC01120022
ZINC02043137
ZINC04552284
ZINC01805618
ZINC02685333
ZINC05260454
ZINC04545932
ZINC05511099
ZINC05235949
ZINC02685401
ZINC03870800
ZINC02685375
ZINC04556500
ZINC05258510
ZINC02685370
ZINC02252499
ZINC04552272
ZINC03871402
ZINC03870109
ZINC04735783
ZINC04523248
ZINC04533781
ZINC04534321
ZINC04543589
ZINC04660890
ZINC04552275
ZINC05511076
ZINC05545035
ZINC02522613
ZINC04735797
ZINC04534319
ZINC04672996
ZINC04523366
ZINC04065004

3908.913
3874.391
3862.188
3857.324
3856.261
3842.097
3832.105
3823.13
3821.942
3818.507
3811.679
3811.322
3808.482
3806.062
3802.661
3801.73
3798.232
3785.887
3780.27
3778.958
3776.205
3771.423
3754.075
3743.268
3740.393
3733.955
3732.108
3731.883
3729.479
3716.438
3712.854
3712.259
3706.273
3701.213
3700.264
3685.927
3664.898
3648.144
3638.23
3623.76
3621.934
3618.054
3616.808
3616.223
3613.007
3605.412
3598.52
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Sigma Aldrich
Otava
Otava
Sigma Aldrich
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Enamine
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Otava
Otava
Sigma Aldrich
Sigma Aldrich
Otava
LifeChemicals
Sigma Aldrich
Sigma Aldrich
Otava
Otava
LifeChemicals
Sigma Aldrich
LifeChemicals
Sigma Aldrich
LifeChemicals
LifeChemicals
Vitas
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Otava
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Sigma Aldrich
Otava
Sigma Aldrich
Otava
Otava
Sigma Aldrich
Otava
Sigma Aldrich
Vitas
Sigma Aldrich
Vitas

ZINC05885060
ZINC05260451
ZINC05273572
ZINC04735821
ZINC01893395
ZINC06590276
ZINC02047153
ZINC04514046
ZINC04677137
ZINC04083848
ZINC04187766
ZINC05511070
ZINC05511066
ZINC05511089
ZINC04735769
ZINC03268222
ZINC04304712
ZINC04739051
ZINC01122862
ZINC04167058
ZINC00969636
ZINC05511112
ZINC01206008
ZINC00038207
ZINC05235951
ZINC04939716
ZINC00653397
ZINC03305588
ZINC02700719
ZINC04373351
ZINC00556918
ZINC02699820
ZINC05516169
ZINC00783224
ZINC03274602
ZINC03218782
ZINC03248836
ZINC01782161
ZINC02710650
ZINC04106684
ZINC03217938
ZINC04513866
ZINC00839413
ZINC04373354
ZINC06590275
ZINC00783223
ZINC03358847

3586.05
3577.245
3568.69
3558.965
3554.209
3528.214
3528.206
3514.745
3492.472
3490.832
3476.841
3470.568
3463.047
3443.054
3406.209
3401.479
3385.03
3373.027
3367.326
3300.651
3290.01
3261.722
3237.435
3231.201
3228.151
3220.544
3201.981
3164.451
3131.295
3124.746
3109.576
3093.368
3086.172
3050.043
3048.249
3035.004
2934.242
2869.992
2829.9
2818.322
2801.973
2798.426
2732.374
2729.865
2702.556
2678.131
2656.639
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Enamine
Sigma Aldrich
Sigma Aldrich
Otava
Otava
Enamine
Sigma Aldrich
Sigma Aldrich
Vitas
Vitas
Vitas
Otava
Otava
Otava
Otava
Enamine
Otava
Vitas
Vitas
LifeChemicals
LifeChemicals
Otava
Otava
TimTec
Otava
LifeChemicals
TimTec
Enamine
LifeChemicals
Asinex
Otava
LifeChemicals
Otava
Asinex
Enamine
Enamine
Enamine
Otava
LifeChemicals
Keyorganics
Enamine
TimTec
TimTec
Asinex
Enamine
Asinex
Enamine

ZINC00074476
ZINC04482492
ZINC02685062
ZINC05827290
ZINC07157728
ZINC04993151
ZINC03269810
ZINC04660889
ZINC04037814

2629.257
2608.585
2599.128
2584.551
2554.532
2544.796
2523.898
2522.86
2517.244
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Asinex
Enamine
Otava
Enamine
Enamine
Asinex
Enamine
Otava
Asinex

APPENDIX B
Descriptor Values for All Antibiotics
Antibiotic

Efflux

LogP

MolWidth

HINTnB

HINTZ3

HINTcE

HINTAcrBHole

1

2

0.22

8.824

1421.4049

349.9535

269.3283

-358.842

2

1.322

0.63

7.8673

-48.9615

208.3675

803.6375

-192.874

3

1

1.67

8.4704

359.8735

-19.4607

759.0005

-563.7534

4

0

0.78

8.5204

895.124

609.4122

1161

-141.4805

5

0

-2.18

8.1583

1180.493

-407.6976

1681.1809

-511.7244

6

1.585

0.14

7.6195

684.2153

654.4504

676.4913

365.8505

7

0

-1.54

8.7335

-234.6077

1042.9979

823.7745

265.72

8

0.585

1.57

8.9935

219.3652

892.0615

1536.8369

152.3447

9

0.585

-0.01

8.6566

727.4464

694.5172

395.6584

-171.2888

10

3.585

-0.24

8.8245

1036.7676

281.1794

-310.9403

-83.5398

11

2.415

-0.05

8.2824

1369.0051

626.1984

624.5814

-1084.8589

12

1

-0.11

11.03

531

840.4

460.5

-476.7

13

0.415

-0.38

8.4421

11.3957

320.7032

-437.5324

-1774.9761

14

0

-0.4

8.3236

1086.635

-342.8607

1831.3839

-471.9541

15

0

0.6

9.5402

420.3004

701.2516

798.1672

-1500.9824

16

4.087

1.92

6.9961

-169.3248

-33.8065

-321.4585

-398.8438

17

0

-1.43

7.8187

266.208

-427.9128

1417.8339

264.2717

18

1.322

1.13

7.0743

673.8554

-441.0727

154.8593

-135.5974

19

1.415

0.88

7.066

883

1188.2214

2641.8313

1230.6249

20

0

0.75

7.7892

1033

724.1004

2229.8894

1100.3538

21

8.585

2.05

8.7708

897.123

-1201.1604

-372.9877

-116.3972

22

1.322

0.37

7.3337

1031.1724

-749.2806

653.3875

-2067.1899

23

5.170

0.21

10.16

576.3

354.8

234.4

-604

24

7

3.21

8.8458

302.0901

-645.2233

12.4986

-891.8931

25

7.415

2.61

8.5613

876.5013

-1601.5297

-667.899

-30.9436

26

2.585

0.2

9.9196

183.9795

-330.1823

355.9706

-324.9861

27

4

0.67

10.9224

49.3987

147.8679

-35.149

-172.376

28

0

0.06

7.87

891.5

265.4

1209.4

-321.2

29

1

1.41

6.9541

1038.7643

-668.0494

-547.1687

-517.5837

30

2

0.24

6.9829

351.8297

-862.1061

-127.8168

-968.7239

31

0

-0.19

7.3593

1248.1177

1084.7677

2562.1274

-356.574

32

0

0.22

8.4364

914.1481

-276.4886

604.3444

-809.584

33

2.585

0.11

7.2725

520.443

1222.7812

1487.6881

-311.5596

34

3

0.98

8.4555

-744.2012

-80.3125

164.3973

42.7482
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35

3

-0.91

9.4782

-278.7676

-67.7812

-786.8657

-1105.425

36

7

2.56

9.3903

419.9081

248.6562

172.3196

-25.4482

37

3

2.1

5.9864

436.4709

339.5

259.7588

231.7992

38

3

-0.56

8.881

-879.8488

-272.5312

-110.5498

-358.8451

39

0

0.15

6.2727

440.6515

259.0312

314.0884

-305.9413

40

5.736

3.07

8.6761

-394.235

-420.5938

982.9062

-493.9512

41

1

0.95

9.6246

360.6436

321.3438

-264.627

-638.6501

42

8

4.33

9.0142

318.0577

110.0312

921.7446

-49.2852

43

2

-0.57

9.0729

62.2588

587.7812

-621.0016

-471.9078

44

0

-0.47

9.4612

-44.4861

440.125

-599.4806

-651.1274
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